The 2021 Congress Learning Objectives are as follows:
After this educational event, attendees should be able to:
- Recall and contrast the latest advances in genitourinary cancer diagnosis, staging, and management
- Discuss advanced cancer treatments, including immunotherapy for genitourinary cancers
- Discuss the latest advances in robotic platforms and minimally invasive surgical techniques in urology
- Describe the causes and treatment of lower urinary tract dysfunction, including the newest therapies for prostate enlargement
- Summarize the pathophysiology and management of genitourinary fistulae and stricture disease
- Describe emerging urological infections and the impact of COVID-19 on urological care
- Detail surgical approaches to urinary stone disease
- List common genital emergencies and their management
- Characterize the assessment and management of male infertility
- Define treatment options for erectile dysfunction and learn new skills in the principles of penile prosthesis placement
- Recall urologic issues specific to the geriatric population
- List hormonal treatments for urologic patients
- Present diagnostic and management approaches to common pediatric urological diseases
SIU 2021 Scientific Programme
Last updated: November 30, 2021
Please Note: All session times are listed in Gulf Standard Time (GST).
To view the PDF version of the Scientific Programme, please click here.
To view a list of unmoderated ePosters, please click here.
To view a list of moderated and residents’ forum ePosters, please consult the Scientific Programme for those sessions.
Wednesday, November 10
Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.
0800-1000
|
|
SYMP-02: Pan-African Urological Surgeons Association (PAUSA) Symposium
Room: Abu Dhabi A
Chair: Mohamed Jalloh, Senegal
|
|
|
SESSION I: Minimally Invasive Urologic Surgery
Moderators Mohamed Jalloh, Senegal E. Oluwabunmi Olapade-Olaopa, Nigeria
|
0800-0820
|
|
What Urologist Needs to Know About Endourologic Equipment Before Urinary Stone Treatment?
Khaled Atallah, Tunisia
|
0820-0835
|
|
Laparoscopy in Urology: Perspectives in Africa
Cyril Kamadjou, Cameroon
|
0835-0850
|
|
Developing Endourology in Africa, the Nigerian Experience with “NAUS- Karl Storz Endourology Roadshow’
Alexander M.E. Nwofor, Nigeria
|
0850-0900
|
|
Q&A
|
|
|
SESSION II: General Urology
Moderators Serigne Magueye Gueye, Senegal Cyril Kamadjou, Cameroon
|
0900-0920
|
|
Epidemiology and Types of Urinary Lithiasis in Senegal
Lamine Niang, Senegal
|
0920-0935
|
|
Antibiotics Resistance Pattern in Urology Patients in Western Kenya
Willis Oyieko, Kenya
|
0935-0950
|
|
Maintaining a Scientific Basis Is Essential for Contemporary Urological Practice
E. Oluwabunmi Olapade-Olaopa, Nigeria
|
0950-1000
|
|
Q&A
|
|
0800-1000
|
|
SYMP-03: International Society of Reconstructive Urology (ISORU) Symposium
Room: Abu Dhabi B
Co-Chairs: Pankaj Joshi, India / Paksi Satyagraha, Indonesia
|
0800-0805
|
|
Introduction
Pankaj Joshi, India Paksi Satyagraha, Indonesia
|
0805-0814
|
|
Fossa Navicularis Stricture
Dmitriy Nikolavsky, United States
|
0814-0823
|
|
Non Transection Bulbar Urethroplasty
Stella Ivaz, United Kingdom
|
0823-0832
|
|
2 Stage BMG Urethroplasty
Saskia C Morgenstern, Germany
|
0832-0841
|
|
Strictures in Africa
Evelyn Mmapula Moshokoa, South Africa
|
0841-0855
|
|
Expert Comments/ Q&A
|
0855-0904
|
|
Setting up a Congenitilism Unit
Gunter De Win, Belgium and UK
|
0904-0913
|
|
Demographics of Urethral Stricture
Faisal Alhajeri, Kuwait
|
0913-0922
|
|
Roaming Reconstructive Urologist
Paksi Satyagraha, Indonesia
|
0922-0931
|
|
Hypospadias Fistula
Pankaj Joshi, India
|
0931-0940
|
|
Reaching 100 cases after Fellowship
Devang Desai, Australia
|
0940-0955
|
|
Expert Comments/ Q&A
|
0955-1000
|
|
Closing Remarks
Pankaj Joshi, India Paksi Satyagraha, Indonesia
|
|
0830-1200
|
|
SYMP-01: 9th Symposium on Affordable New Technologies in Urology (SANTU) and Best Affordable New Technologies in Urology Contest (BANTUC)
Room: Ras Al Khaimah
Co-Chairs: Arvind Ganpule, India / Mohammed Lezrek, Morocco Honorary Chair: Daniel Yachia, Israel
|
0830-0835
|
|
Opening SANTU-9
Mohammed Lezrek, Morocco
|
0835-0900
|
|
Moderated Posters
Presenters Abdulrahman Al Aown, Saudi Arabia Sakineh Hajebrahimi, Iran Wissam Kamal, Saudi Arabia Rami Labib, United Arab Emirates Taofiq Olayinka Mohammed, Nigeria Seshu Mohan Khetavath, India Egon Ilman Saputra, Indonesia Mriganka Mani Sinha, United Kingdom Sai Venkat Manoj Tummala, India
|
|
|
SANTU Lectures
|
0900-0915
|
|
Practical Endourology for the Global Surgeon
Kymora Scotland, United States
|
0915-0930
|
|
How to Help Medical Technology Development in Low-income Countries
Fabian Jodeit, Germany
|
0930-0945
|
|
How to Create a Frugal Innovation
Daniel Yachia, Israel
|
0945-1000
|
|
The Way to Affordable Innovation
Mohammed Lezrek, Morocco
|
|
|
Affordability Session
|
1000-1010
|
|
The Unmet Need: The Genesis of the Idea
Ashish Rawandale-Patil, India
|
1010-1020
|
|
How do We Develop the Cost-effective Innovations into a Product?
Arvind Ganpule, India
|
1020-1030
|
|
Conundrum of Regulatory and Patent-related Issues: Developing Countries vs. Developed Countries
Ashish Rawandale-Patil, India
|
1030-1040
|
|
How Can the Innovator Safeguard his Interest (Financial and Intellectual Property-related)?
Daniel Yachia, Israel
|
1040-1050
|
|
Q&A
|
|
|
4th Best Affordable New Technologies in Urology Contest (BANTUC)
|
1050-1055
|
|
Presentation of 4th BANTUC
Daniel Yachia, Israel
|
1055-1145
|
|
Presentation of the Projects by the Finalist List
|
1055-1105
|
|
Reconstructed 20 mL Syringe Evacuator as an Alternative to Bladder Syringe/Ellick Evacuator for Clot Retention Evacuation in Rural Communities
Taofiq Olayinka Mohammed, Nigeria
|
1105-1115
|
|
Cheap and Accessible 3D Printed Metal Dilators for Low-resource Settings
Marlon Perera, Australia
|
1115-1125
|
|
Ash bag: A Simple Remedy in the Management for Urine Leak
Krishnasamy Kannan, India
|
1125-1135
|
|
Laparoscopic Port Lithotripter: An Affordable and Low Cost New Technique for Pneumatic Stone Destruction
Mohamed Al Ameedee, Iraq
|
1135-1145
|
|
Q&A
|
1145-1155
|
|
Announcement of the Results and Awards Distribution of 4th BANTUC & Invitation to 5th BANTUC
Presenter: Daniel Yachia, Israel
|
1155-1200
|
|
Closing SANTU-9 and Invitation to SANTU-10, 2022
Arvind Ganpule, India
|
|
0900-1200
|
|
SYMP-04: Indian Urology Around the World Symposium
Room: Umm Al Quwain
Co-Chairs: Chiruvella Mallikarjuna, India / Keshavamurthy Ramaiah, India
|
0900-0905
|
|
Welcome Address
Christopher Evans, United States Chiruvella Mallikarjuna, India
|
0905-0915
|
|
Overcoming Challenging Problems during Flexible Ureteroscopy
Kandarp Parikh, India
|
0915-0925
|
|
Dust or Bust: A Beginners Guide to Modern Day Laser Lithotripsy Srategies for Ureteroscopy
Thimme Gowda Manohar, India
|
|
|
Tips & Tricks in Urologic Surgery (Semi-Live)
|
0925-0940
|
|
Ureteroscopy
Tanuj Bhatia, India
|
0940-0955
|
|
PCNL
Ravindra Sabnis, India
|
0955-1005
|
|
SECOND OPINION : How to Manage a 65-year old Man with Bothersome LUTS due to BPE with Underactive Detrusor
Sanjay Sinha, India
|
1005-1015
|
|
New Techniques of Treating BPH – Are They Far from Practical Reality...!?
Pankaj Wadhwa, India
|
1015-1025
|
|
Nocturia in Elderly Male - Continuing Dilemma
Sanjay Sinha, India
|
1025-1035
|
|
The Imaging Gap in Stone Disease - Whose Fault Is It?
Arun Chawla, India
|
1035-1110
|
|
Black Pearls Session: Complications in Laparoscopy & Robotic Urologic Surgery
Panelists Arvind Ganpule, India Chiruvella Mallikarjuna, India
|
1110-1150
|
|
Controversies in Surgical Stone Management: A Case Based Discussion
Moderators Keshavamurthy Ramaiah, India Ravindra Sabnis, India
Panelists Arun Chawla, India Arvind Ganpule, India Kandarp Parikh, India
|
1150-1200
|
|
Concluding Remarks
Keshavamurthy Ramaiah, India
|
|
1000-1210
|
|
SYMP-05: Society of Genitourinary Reconstructive Surgeons (GURS) Symposium
Room: Abu Dhabi B
Chair: Jairam Eswara, United States
|
1000-1002
|
|
Introduction
Jairam Eswara, United States
|
|
|
TOPIC A: Male and Female Lower Urinary Tract (LUT) Reconstruction
|
1002-1012
|
|
Challenges in the Management of LUT Trauma
Drew Peterson, United States
|
1012-1022
|
|
Therapeutic Challenges in Female Genitourinary Fistulae
Farzana Cassim, South Africa
|
1022-1032
|
|
Difficult Urethral Strictures in Complex Settings (Lichen Sclerosus, Iatrogenic, and Radiation-Induced)
Matthias Hofer, United States
|
1032-1042
|
|
Female Urethroplasty: Any Evidence-Based Guidelines for Treatment?
Mélanie Aubé-Peterkin, Canada
|
1042-1047
|
|
Q&A
|
|
|
TOPIC B: Troubleshooting Complications in Genitourinary Reconstruction: Learning from Our Mistakes
|
1047-1057
|
|
Failed PFUI Repair
Akio Horiguchi, Japan
|
1057-1107
|
|
Options for Failed Ureteric Reconstruction
Bhavatej Enganti, India
|
1107-1117
|
|
Failure of Recurrent Surgical Treatment for Post-Prostatectomy Incontinence: What Next?
Henriette Veiby Holm, Norway
|
1117-1127
|
|
When Further Reconstruction is Futile in Irradiated Pelvis: The Case for Urinary Diversion
Sean P. Elliott, United States
|
1127-1132
|
|
Q&A
|
|
|
TOPIC C: Challenges in Penile Prosthesis Implantation
|
1132-1142
|
|
Following Penile Fracture and Trauma
Cooper Benson, United States
|
1142-1152
|
|
Penile Implantation in Transmen
Mang Chen, United States
|
1152-1202
|
|
Following Prior IPP Infection-Erosion
Eric Chung, Australia
|
1202-1207
|
|
Q&A
|
1207-1210
|
|
Closing Remarks
Jairam Eswara, United States
|
|
1300-1520
|
|
SYMP-06: Joint SIU-Chinese Urological Association (ChUA) Symposium
Room: Ras Al Khaimah
Co-Chairs: Badrinath Konety, United States / Li-Ping Xie, People's Republic of China
|
1300-1345
|
|
Bladder Infections
Moderators Nicolae Crisan, Romania Guohua Zeng, China
|
1300-1315
|
|
Treatment Strategies in Recurrent UTI
Guohua Zeng, China
|
1315-1330
|
|
Treatment of UTI in Pediatric Cases
M. Ihsan Karaman, Türkiye
|
1330-1345
|
|
Biofilm and its Implications in Urology
Ranan Dasgupta, United Kingdom
|
1345-1415
|
|
Bladder Cancer NMIBC
Moderators Ahmet Yaser Müslümanoğlu, Türkiye Miguel Ramos, Portugal
|
1345-1400
|
|
Image 1S, NBI or PDD – Which One to Use?
Paolo Gontero, Italy
|
1400-1415
|
|
Why Should You do En-bloc Resection?
Josep Maria Gaya Sopena, Spain
|
1415-1445
|
|
Bladder Cancer MIBC
Moderators Patrick Coloby, France Richard Hautmann, Baden-Württemberg
|
1415-1430
|
|
Uretero-enteric strictures following radical Cystectomy
Raed Azhar, Saudi Arabia
|
1430-1445
|
|
Chemotherapy in MIBC: When and How?
Özcan Yıldız, Turkey
|
1445-1515
|
|
Upper Tract Urothelial Cancer
Moderators Michael Grasso, United States Chiruvella Mallikarjuna, India
|
1445-1500
|
|
Indications and Outcomes of Conservative Treatment
Joyce Baard, The Netherlands
|
1500-1515
|
|
Preventive Strategies of Bladder Recurrence Following UTUC Treatment
Manuel Castanheira de Oliveira, Portugal
|
1515-1520
|
|
Closing Remarks
Badrinath Konety, United States Li-Ping Xie, People's Republic of China
|
|
1300-1510
|
|
SYMP-08: Kenya Association of Urological Surgeons (KAUS) and South African Urological Association (SAUA) Symposium
Room: Abu Dhabi A
Co-Chairs: Patrick Mburugu, Kenya / Saeed R. Samnakay, Kenya
|
1300-1305
|
|
Welcome
Saeed R. Samnakay, Kenya Simon Tanguay, Canada
|
1305-1320
|
|
Use of Buccal Mucosal Graft to Repair Complex Hypospadias as Two Stage Procedure - Review of First Sixty Cases
Frederik Claassen, South Africa
|
1320-1335
|
|
The Influence of Covid-19 Pandemic on Accessibility to TURBT Among Bladder Cancer Patients Seen at Kenyatta National Hospital, Nairobi
Ernest Kimani, Kenya
|
1335-1350
|
|
Public and Private Partnership in Maximizing Teaching in Urology During the Covid Era
Evelyn Mmapula Moshokoa, South Africa
|
1350-1405
|
|
Genetics of Prostate Cancer
Samkele Salukazana, South Africa
|
1405-1420
|
|
Prostate Cancer Age-Standardized Incidence Increase Between 2006 and 2016 in Gauteng Province, South Africa: A Laboratory Data-Based Analysis
Ahsan Ahmad, South Africa
|
1420-1435
|
|
An Update on Percutaneous Nephrolithotomy
Ahmed Yousef, Egypt
|
1435-1450
|
|
Misplaced DJ Stent Dislodged After A-H Pyeloplasty in 15-Year Old Male
Maurice Wambani, Kenya
|
1450-1505
|
|
Discussion
|
1505-1510
|
|
Take Home Message
Patrick Mburugu, Kenya Saeed R. Samnakay, Kenya
|
|
1500-1645
|
|
SYMP-11: Symposium on Focal Therapy
Room: Dubai CD
Co-Chairs: Jean de la Rosette, Türkiye / Jurgen Fütterer, The Netherlands / Rafael Tourinho-Barbosa, Brazil
|
|
Learning Objective:
Following this session, attendees will be able to foster a FT session in both renal and prostate cancer to further improve the understanding of an organ-sparing approach.
|
1500-1507
|
|
Introduction
Jean de la Rosette, Türkiye Jurgen Fütterer, The Netherlands Rafael Tourinho-Barbosa, Brazil
|
1507-1522
|
|
We Identify the Index Lesion with pMRI: Current Limitations of pMRI in the Evaluation of Prostate Cancer
Robert Reiter, United States
|
1522-1537
|
|
Micro-ultrasound Guided Biopsies: Dismissing or Adding Value to mpMRI?
Rafael Tourinho-Barbosa, Brazil
|
1537-1552
|
|
Transitioning from MRI Fusion Biopsy to Focal Therapy
Ezequiel Becher, Argentina
|
1552-1607
|
|
Focal Therapy for PCa: What Is Really Needed to Move from Investigational to Valid Therapeutic Alternative?
Armando Stabile, Italy
|
1607-1622
|
|
Tumour Microenvironment and Focal Therapy for Prostate Cancer: Are We Missing Something?
Giancarlo Marra, Italy
|
1622-1637
|
|
Post-Focal Therapy Assessment: Biopsy and Salvage Options after Focal Therapy Recurrence
Samuel Chi-Hang Yee, Hong Kong
|
1637-1645
|
|
Conclusion
Jean de la Rosette, Türkiye Jurgen Fütterer, The Netherlands Rafael Tourinho-Barbosa, Brazil
|
|
Thursday, November 11
Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.
0730-0900
|
|
SYMP-07: Urological Association of Asia (UAA) Symposium
Co-Chairs: Allen W. Chiu, Taiwan / Myung-Soo Choo, South Korea
|
0730-0735
|
|
Welcome and Introduction
Allen W. Chiu, Taiwan
|
|
|
Part 1: Urolithiasis
|
0735-0743
|
|
Simulated Training in Endourology
Shuji Isotani, Japan
|
0743-0751
|
|
Prolonging Life of Flexible Ureteroscopes
Anthony Chi-Fai Ng, Hong Kong
|
|
|
1.5cm Upper Ureteric Stone; What’s Best in Asia?
|
0751-0759
|
|
PCNL
Bannakij Lojanapiwat, Thailand
|
0759-0807
|
|
Laparoscopy
Panelist: Teng Aik Ong, Malaysia
|
|
|
Part 2: Advanced Urological Malignancies
|
0807-0815
|
|
Precision Medicine in Prostate Cancer
Masatoshi Eto, Japan
|
0815-0823
|
|
Decreasing Complications of Radical Cystectomy
William Huang, Taiwan
|
0823-0838
|
|
Cost Matters when Using Advanced Therapies for Cancer
Shrawan Kumar Singh, India
|
|
|
Part 3: Andrology and Infertility
|
0838-0846
|
|
PRP for Erectile Dysfunction
Ahmad Shamsodini, Qatar
|
0846-0952
|
|
Managing Peyronie’s Disease in 2021
Rupin Shah, India
|
0852-0900
|
|
Fertility Issues in Boys with Cancers
Poongkodi Nagappan, Malaysia
|
0859-0900
|
|
Take Home Message
Myung-Soo Choo, South Korea
|
|
0730-0850
|
|
SYMP-10: Joint SIU-Korean Urological Association (KUA) Symposium
Co-Chairs: Stavros Gravas, Cyprus / Sung Kyu Hong, South Korea
|
0730-0735
|
|
Welcome Address by KUA and SIU President
Sanjay Kulkarni, India Sang Don Lee, South Korea
|
|
|
Endourology
Moderator: Ill Young Seo
|
0735-0745
|
|
No Touch Technique in Ureteroscopy
Petrisor Aurelian Geavlete, Romania
|
0745-0755
|
|
Hand-Assisted Laparoscopic Surgery (HALS) in Urology: Is it Still Alive?
Sunghyun Paick, South Korea
|
0755-0805
|
|
ECIRS: Indications, Tips and Tricks
Daniel Pérez-Fentes, Spain
|
|
|
Oncology
Moderator: Ho Kyung Seo, South Korea
|
0805-0815
|
|
Partial Nephrectomy: When Open and When Laparoscopic/Robotic
Archil Chkhotua, Georgia
|
|
|
Pediatrics & Voiding Dysfunction
Moderator: Sang Don Lee, South Korea
|
0815-0825
|
|
OAB Medical Treatment Update
Martin Michel, Germany
|
0825-0835
|
|
Incontinence Treatment in Transitional Urology
Jang Hwan Kim, South Korea
|
0835-0845
|
|
Adolescent Varicocele: To Treat or Not to Treat
M. Ihsan Karaman, Türkiye
|
0845-0850
|
|
Closing Remarks
Jean de la Rosette, Türkiye Sang Don Lee, South Korea
|
|
0730-1500
|
|
LS: Semi-Live Surgery
Room: Sheikh Rashid CDF
Co-Chairs: Jean de la Rosette, Türkiye / Thomas Herrmann, Switzerland
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Recognize important considerations in the surgical techniques for reconstructive surgery, such as penile prosthesis, male sling, etc., and select the best reconstructive approach for complex cases
- Learn from other professionals’ clinical experience with surgical conditions, including clinical management, multidisciplinary care, and clinical outcomes
- Demonstrate practical knowledge related to instrumentation techniques for upper and lower urinary tract cases via surgical and emerging minimally invasive approaches
- Learn about emerging procedures in the area of robotics in oncology
- Demonstrate the use of imaging to perform targeted and systematic biopsies
- Learn about minimal invasive treatment options for localized prostate cancer using focal therapy
|
0730-0900
|
|
Focal Therapy and Imaging
Moderators Jurgen Fütterer, The Netherlands Mauro Gacci, Italy Sung Kyu Hong, South Korea Rahim Horuz, Türkiye Armando Stabile, Italy Rafael Tourinho-Barbosa, Brazil
|
|
|
Surgeries:
|
|
|
Micro-Ultrasound/MRI Fusion Biopsy with Real Time Visualization
Surgeon: Petr Macek, France
|
|
|
Focal One Treatment
Surgeon: Franck Bladou, France
|
|
|
IRE Focal Treatment
Surgeon: José Luis Domínguez-Escrig, Spain
|
0900-1100
|
|
Reconstructive Surgery
Moderators Avelino Fraga, Portugal Reynaldo Gómez, Chile Serigne Magueye Gueye, Senegal Kurt McCammon, United States
|
|
|
Surgeries:
|
|
|
Penile Implant
Surgeon: Koenraad van Renterghem, Belgium
|
|
|
Urethral Repair
Surgeon: Evelyn Mmapula Moshokoa, South Africa
|
|
|
Peyronie's Surgery
Surgeon: Ates Kadıoğlu, Türkiye
|
|
|
Fistula Repair
Surgeon: Tamsin Greenwell, United Kingdom
|
1100-1300
|
|
Endourology
Moderators Abdullatif Al-Terki, Kuwait Anastasios Anastasiadis, Greece Mélanie Aubé-Peterkin, Canada Vincent De Coninck, Belgium Sanjay Khadgi, Nepal
|
|
|
Surgeries:
|
|
|
Mini PCNL plus US
Surgeon: Madhu Sudan Agrawal, India
|
|
|
RIRS with Holmium Lithotripsy
Surgeon: Leye Ajayi, United Kingdom
|
|
|
TUEP
Surgeon: Thomas Herrmann, Switzerland
|
|
|
Aquablation
Surgeon: Mihir Desai, United States
|
1300-1500
|
|
Uro-oncology
Moderators Piotr Chlosta, Poland Mahesh R. Desai, India Andrés Hernández-Porras, Mexico Pilar Laguna, Türkiye Richard Mallet, France
|
|
|
Surgeries:
|
|
|
UTUC
Surgeon: Olivier Traxer, France
|
|
|
En-bloc TURBT
Surgeon: Jeremy Yuen-Chun Teoh, Hong Kong
|
|
|
Robotic Partial Nephrectomy
Surgeon: Raed Azhar, Saudi Arabia
|
|
|
Robotic Cystectomy
Surgeon: Mevlana Derya Balbay, Türkiye
|
|
0730-1630
|
|
SYMP-12: World Urological Oncology Federation (WUOF) Symposium - Advances in Systemic Therapeutics
Room: Sheikh Maktoum BC
Co-Chairs: Peter Hammerer, Germany / Laurence Klotz, Canada
|
|
|
Sessions 2 and 3, exclusively, will be broadcast live on SIU@U |
|
0730-0755
|
|
Welcome & Introductions
Peter Hammerer, Germany Laurence Klotz, Canada
|
0755-0810
|
|
Framing of Theme
Peter Hammerer, Germany Laurence Klotz, Canada
|
0810-1010
|
|
Session One | Advanced Prostate Cancer
|
0815-0830
|
|
Optimizing Treatment for Locally Advanced Prostate Cancer
Peter Hammerer, Germany
|
0830-0845
|
|
Molecular Imaging to Assess PCa Biology and Differentiation
Frédéric Pouliot, Canada
|
0845-0900
|
|
Genomics and Novel Markers for Identification of Inherited PCa Risk
Muhammad Bulbul, Lebanon
|
0900-0915
|
|
Precision Medicine in CRPC
Christopher Evans, United States
|
0915-0930
|
|
ADT and Cardiovascular Disease - Myths and Misperceptions
Jehonathan Pinthus, Canada
|
0930-0955
|
|
Discussion
|
0955-1010
|
|
Coffee Break
|
1010-1230
|
|
Session Two | Bladder Cancer
|
1015-1030
|
|
Genomics of Bladder Cancer
Alexandre Zlotta, Canada
|
1030-1045
|
|
Sexual Dimorphism in Bladder Cancer - Implications for Management
Robert Siemens, Canada
|
1045-1100
|
|
Tri-modal Therapy for MIBC: Role of the Urologic Oncologist
Adam Feldman, United States
|
1100-1115
|
|
Proteogenomics and Predicting Sensitivity to Chemotherapy
Seth Lerner, United States
|
1115-1130
|
|
Regionalization of Bladder Cancer Care
Girish Kulkarni, Canada
|
1130-1145
|
|
Combined Radiation with Checkpoint Inhibitors in Bladder Cancer
Wassim Kassouf, Canada
|
1145-1200
|
|
Bladder and Upper Tract Urothelial Cancer - Fraternal Twins or Distant Cousins
Peter Black, Canada
|
1200-1220
|
|
Discussion
|
1220-1230
|
|
Leadership Transition – Succession of WUOF Chair
|
1230-1330
|
|
Working Lunch
Meal vouchers required for all registered attendees |
1335-1510
|
|
Session Three | Kidney Cancer
|
1340-1355
|
|
Population Screening for Kidney Cancer
Grant Stewart, United Kingdom
|
1355-1410
|
|
Surgical Insights for Management of Non-Clear Histology of RCC
Gennady Bratslavsky, United States
|
1410-1425
|
|
Molecular Biomarkers in RCC and Personalized Therapy
Anil Kapoor, Canada
|
1425-1440
|
|
Current Status of Cytoreductive Nephrectomy in the IO Era
Ricardo Rendon, Canada
|
1440-1455
|
|
Immune Checkpoint Inhibitor Combination Therapy in Primary Metastatic Clear-Cell RCC
Axel Bex, United Kingdom
|
1455-1510
|
|
Nephrectomy in the Treatment Sequence of Metastatic RCC
Peter Mulders, The Netherlands
|
1510-1525
|
|
Discussion
|
1525-1645
|
|
Session Four | PCA Localized
|
1530-1545
|
|
Getting Into and Under the ‘Hood of Prostate Cancer Racial Disparities
Matthew Cooperberg, United States
|
1545-1600
|
|
Micro-Ultrasound in the Detection and Staging of Prostate Cancer
Guram Karazanashvili, Georgia
|
1600-1615
|
|
Focal Therapy: Clinical Trials to Clinical Practice
Behfar Ehdaie, United States
|
1615-1630
|
|
How to Define Success After Focal Therapy
Rafael Sanchez-Salas, Canada
|
1630-1645
|
|
Discussion
|
|
0800-1500
|
|
TIPS-01: SIU Tips and Tricks Session - SIU Academy & SIU Journal
Room: Ras Al Khaimah
Co-Chairs: Peter Black, Canada / Sean P. Elliott, United States / Stavros Gravas, Cyprus
|
|
Learning Objectives:
At the end of the SIU Academy session, attendees will be able to:
- Define the position of Social Media and Telemedicine in Urology Practice
- List the contemporary challenges and opportunities for Medical Training
- Discuss issues specific to diversity and discrimination in training
At the end of the SIU Journal session, attendees will be able to:
- Identify the requisite characteristics of a reputable journal and distinguish such journals from predatory journals
- Understand the components of a high quality peer review of a journal article
- Write a coherent and succinct research manuscript
|
0800-1000
|
|
SIU Academy
Co-Chairs Sean P. Elliott, United States Stavros Gravas, Cyprus
|
0800-0830
|
|
Social Media as an Educational Tool
|
|
|
Cons
Yasser Farahat, United Arab Emirates
|
|
|
Pros
Dean Elterman, Canada
|
|
|
Consensus
Dean Elterman, Canada Yasser Farahat, United Arab Emirates
|
0830-0845
|
|
Developing a Telemedicine program: Challenges and Considerations
Jeremy Yuen-Chun Teoh, Hong Kong
|
0845-0900
|
|
Training in Urology in the Era of CoVID-19 and Beyond
Athanasios Dellis, Greece
|
0900-0915
|
|
SIU Scholarships and Training Opportunities
Pilar Laguna, Türkiye
|
0915-0930
|
|
Equity and Inclusion in Urological Training
Amanda Chung, Australia
|
0930-1000
|
|
Panel Discussion
|
1000-1300
|
|
Break
|
1300-1500
|
|
SIU Journal
Chair: Peter Black, Canada
|
1300-1305
|
|
Introduction
Peter Black, Canada
|
1305-1320
|
|
Urologic Publishing in 2021
Robert Siemens, Canada
|
1320-1328
|
|
Q&A
|
1328-1343
|
|
The Perfect Journal
Michael Leveridge, Canada
|
1343-1351
|
|
Q&A
|
1351-1406
|
|
Caveat Emptor: Pseudojournals in Urology
Rajeev Kumar, India
|
1406-1414
|
|
Q&A
|
1414-1429
|
|
The Perfect Paper
Thomas Herrmann, Switzerland
|
1429-1437
|
|
Q&A
|
1437-1452
|
|
The Perfect Review
Mario I. Fernández, Chile
|
1452-1500
|
|
Q&A
|
|
1000-1200
|
|
SYMP-13: Joint SIU-Confederación Americana de Urología (CAU) Session (in English)
Room: Abu Dhabi A
Co-Chairs: Andrés Hernández-Porras, Mexico / Alejandro Rodriguez, United States
|
|
To foster a Urologic Oncology session showing the latest advances in prostate, kidney, and bladder cancers with a perspective from an active Urologist in the CAU.
To improve the understanding of an organ sparing approach the latest advances in prostate, kidney, and bladder cancers.
|
|
1000-1200
|
|
SYMP-14: Arab Urology Around the World (AAU) Symposium
Room: Sheikh Rashid A
Chair: Raed Azhar, Saudi Arabia
|
1000-1009
|
|
Welcome Remarks
Jean de la Rosette, Türkiye Yasser Farahat, United Arab Emirates Rajeev Kumar, India
|
1009-1021
|
|
Endo of Stone Age
Saeed Bin Hamri, Saudi Arabia
|
1021-1033
|
|
Robotic Management of Urolithiasis
Rabii Madi, United Arab Emirates
|
1033-1045
|
|
Lithotripsy in Percutaneous Nephrolithotomy
Mudhar Nazar Hasan, United Arab Emirates
|
1045-1057
|
|
Laser Prostatectomy: Developing Countries’ Perspectives
Ahmed Elshal, Egypt
|
1057-1109
|
|
Management of Glans Deformities Following Penile Prosthesis Insertion
Amjad Alwaal, Saudi Arabia
|
1109-1121
|
|
Q&A / Discussion
|
1121-1133
|
|
Difficult Surgical Decisions in RCC
Muhammad Bulbul, Lebanon
|
1133-1145
|
|
Practice-Changing Advances in Bladder Cancer in 2021
Wassim Kassouf, Canada
|
1145-1157
|
|
Current Perspectives in the Management of Upper Tract Urothelial Carcinoma
Sultan Saud Alkhateeb, Saudi Arabia
|
1157-1209
|
|
Urology Training in the Arab World: Example from Kuwait Institute for Medical Specialization (KIMS)
Saad Aldousari, Kuwait
|
1209-1215
|
|
Closing Remarks
Raed Azhar, Saudi Arabia
|
|
1000-1300
|
|
SYMP-16: Joint SIU-Federation of ASEAN Urological Associations (FAUA) Session
Room: Umm Al Quwain
Chair: Noor Ashani Bin Md. Yusoff, Malaysia
|
1000-1010
|
|
Welcome Remarks
Pilar Laguna, Türkiye Teng Aik Ong, Malaysia
|
|
|
Part 1: Reconstructive Surgery in Urology - Establishing Reconstructive Urology Service in South East Asia (SEA)
Moderators Arun Chawla, India Paksi Satyagraha, Indonesia
|
1010-1025
|
|
Reconstructive Urology Conundrum in Subsaharan Africa
Serigne Magueye Gueye, Senegal
|
1025-1040
|
|
Collaboration in Reconstructive Urology for South East Asia (SEA)
Saiful Azli, Malaysia
|
1040-1055
|
|
The Challenge in Establishing Reconstructive Service in Daily Practice
Mark Joseph Abalajon, The Philippines
|
1055-1110
|
|
How to Start and Learn from Mistakes in Reconstructive Urology
Kuncoro Adi, Indonesia
|
|
|
Part 2: Transplant Urology Services
Moderators Mahesh R. Desai, India Samuel Yrastorza, The Philippines
|
1110-1125
|
|
Laparoscopy Donor Nephrectomy
Ernesto Gerial Jr., The Philippines
|
1125-1140
|
|
Early Urological Complications of Live Related Renal Transplant: How to Prevent and Solve Them
Tohid MS Hossain, Bangladesh
|
1140-1155
|
|
Transplant Program in Malaysia
Vijayan Manogran, Malaysia
|
1155-1210
|
|
Robot Assisted Laparoscopic Living Donor Nephrectomy at Cho Ray Hospital
Sam Minh Thai, Vietnam
|
|
|
Part 3: Laparoscopic and Robotic Surgery in Urology in SEA
Moderators Simon Tanguay, Canada Noor Ashani Bin Md. Yusoff, Malaysia
|
1210-1225
|
|
Robotic Prostatectomy: Worth the Cost?
Mudhar Nazar Hasan, United Arab Emirates
|
1225-1240
|
|
Singapore Experience with Retzius Sparing Radical Prostatectomy: Why I Stopped
Terence Lim Sey Kiat, Singapore
|
1240-1255
|
|
Current Status of Robotic Uro-oncological Surgery in Thailand
Kittinut Kijvikai, Thailand
|
1255-1310
|
|
Early Experience of Robotic Assisted Lap RPLND
Noor Ashani Bin Md. Yusoff, Malaysia
|
1310-1315
|
|
Closing Remarks
Teng Aik Ong, Malaysia Noor Ashani Bin Md. Yusoff, Malaysia
|
|
1300-1500
|
|
SYMP-15: Iranian Urological Association (IUA) Symposium
Room: Sheikh Rashid A
Co-Chairs: Abbas Basiri, Iran / Mauro Gacci, Italy
|
|
1300-1500
|
|
SYMP-17: International Neuro-Urology Society (INUS) Symposium
Room: Umm Al Quwain
Chair: Helmut Madersbacher, Austria
|
|
1500-1700
|
|
SYMP-18: Hellenic Urological Association (HUA) Symposium - Current Status and Future Directions in the Treatment of RCC
Room: Dubai CD
Co-Chairs: Ioannis Gkialas, Greece / Mohamad Moussa, Lebanon
|
1500-1505
|
|
Introduction
Ioannis Gkialas, Greece Mohamad Moussa, Lebanon
|
1505-1525
|
|
Renal Biopsy: Where do We Stand?
Athanasios Dellis, Greece
|
1525-1545
|
|
Surveillance in Small Renal Masses
Stavros Gravas, Cyprus
|
1545-1605
|
|
NSS for Small Renal Masses (SRMs)
Athanasios (Thanos) Papatsoris, Greece
|
1605-1625
|
|
Cytoreductive Nephrectomy in the CARMENA Era
Petros Sountoulides, Greece
|
1625-1645
|
|
Smashing News in Systemic Therapy
Petros Grivas, United States
|
1645-1700
|
|
Discussion/Q&A
Athanasios Dellis, Greece Ioannis Gkialas, Greece Stavros Gravas, Cyprus Mohamad Moussa, Lebanon Athanasios (Thanos) Papatsoris, Greece Petros Sountoulides, Greece
|
|
1500-1700
|
|
SYMP-19: EurAsian Urooncology Association (EUA) Symposium
Room: Sheikh Rashid A
Co-Chairs: Ates Kadıoğlu, Türkiye / Ahmet Yaser Müslümanoğlu, Türkiye
|
|
1700-1830
|
|
OC: Opening Ceremonies
Room: Sheikh Rashid CDF
|
Friday, November 12
Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.
0730-0900
|
|
IC-01: Instructional Course 01 - PCNL Tips/Tricks and Pitfalls
Room: Dubai CD
Co-Chairs: Mohamad Moussa, Lebanon / Athanasios (Thanos) Papatsoris, Greece
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Prepare a patient for a successful PCNL (e.g., optimize patients with UTI or severe obesity, choose proper imaging and positioning as well as select the best calyx to enter the PC)
- Perform mini PCNL in a simple standardized step by step way
- Achieve a stone-free rate during a standard PCNL
- Prevent nightmare complications and how to manage them
|
0730-0745
|
|
How to Optimize the Patient Pre-Op
Charalampos Fragkoulis, Greece
|
0745-0749
|
|
Q&A
Charalampos Fragkoulis, Greece
|
0749-0804
|
|
How to Simply Perform Miniaturized PCNL
Dimitrios Staios, Greece
|
0804-0808
|
|
Q&A
Dimitrios Staios, Greece
|
0808-0823
|
|
How to Efficiently and Safely Perform Standard PCNL
S. K. Pal, India
|
0823-0838
|
|
The Do's and the Don'ts in Nightmare Cases: Vote for the Best Option!
Athanasios Dellis, Greece
|
0838-0848
|
|
PCNL in Ectopic Kidney
Mahesh R. Desai, India
|
0848-0855
|
|
Q&A
Athanasios Dellis, Greece Mahesh R. Desai, India
|
0855-0900
|
|
Discussion & Take Home Messages
Mohamad Moussa, Lebanon Athanasios (Thanos) Papatsoris, Greece
|
|
0755-0900
|
|
MC-01: Master Class 01 - Advanced Kidney Cancer
Room: Sheikh Rashid A
Co-Chairs: Axel Bex, United Kingdom / Peter Mulders, The Netherlands
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Recall the latest developments in systemic therapy in mRCC
- Compare neo- and adjuvant therapy indications in advanced RCC
- Explain the role of nephrectomy in the systemic setting of RCC
- Apply case-based knowledge in advanced RCC
|
|
0800-0900
|
|
MC-02: Master Class 02 - Refractory Overactive Bladder Syndrome
Room: Sheikh Maktoum D
Co-Chairs: Sanjay Sinha, India / Alan Wein, United States
|
|
0900-1030
|
|
DEMO: Demo Session: Tips and Tricks in fURS
Room: Abu Dhabi B
Chair: Wissam Kamal, Saudi Arabia Faculty: Saeed Bin Hamri, Saudi Arabia / Mudhar Nazar Hasan, United Arab Emirates
|
|
Pre-registration is required for this session
This session will focus more on endourological procedures (RIRS and PCNL) in terms of instrumentation, technique and tips and tricks.
Learning Objectives
- Assess indications of each technique (PCNL and RIRS)
- Compare instrumentation for each technique (disposable vs. reusable equipment)
- Recognize the basics of endoscope manipulation and laser applications
- Understand the principles of management of endourological complications
|
|
0900-1200
|
|
INN-01: Prostate MRI Reading and Fusion Biopsy Hands On Training Course
Room: Sheikh Rashid B
Co-Chairs: Tristan Barrett, United Kingdom / Christof Kastner, United Kingdom
|
|
At the end of this session, attendees will be able to:
- Recall key features of systematic prostate MRI reading according to PI-RADS standards.
- Read and report basic and intermediate level prostate MR imaging with confidence.
- Recognize the technical features and capabilities of prostate biopsy and fusion technology using MR imaging for targeting.
- Identify the key requirements to safely integrate MR imaging into the prostate diagnostic pathway.
|
0900-0905
|
|
Welcome and Introduction to Prostate Cancer Diagnostics and the Role of MRI
Christof Kastner, United Kingdom
|
0905-1040
|
|
MRI Workshop
Tristan Barrett, United Kingdom
|
0905-0917
|
|
Tutorial: Prostate MRI and PI-RADS
Tristan Barrett, United Kingdom
|
0917-0922
|
|
DynaCAD Introduction (Presented by Philips)
|
0922-0957
|
|
Hands-On: MRI Case Analysis DynaCAD - Basic
Tristan Barrett, United Kingdom
|
0957-1005
|
|
Tutorial: Pearls & Pitfalls of Reading and Reporting
Tristan Barrett, United Kingdom
|
1005-1040
|
|
Hands-On: MRI Case Analysis DynaCAD - Basic-Iterm
Tristan Barrett, United Kingdom
|
1040-1055
|
|
Integration of MRI and Fusion Biopsy into the Diagnostic Pathway
Christof Kastner, United Kingdom
|
1055-1130
|
|
Biopsy Workshop
Christof Kastner, United Kingdom
|
1055-1105
|
|
Tutorial: Biopsies Using Prostate MRI
Christof Kastner, United Kingdom
|
1105-1130
|
|
Live & On-Screen Demo by Industry: Advanced Biopsy Equipment
Christof Kastner, United Kingdom
|
1130-1145
|
|
Value and Use of MRI Based Assessment in Treatment Decision and Surveillance of Prostate Cancer
Jurgen Fütterer, The Netherlands
|
1150-1200
|
|
Discussion and Finish
|
|
0900-1045
|
|
PL-01: Plenary 01
Room: Sheikh Rashid CDF
Honorary Chairs: Christopher Evans, United States / Sanjay Kulkarni, India / Rajeev Kumar, India
|
0900-0905
|
|
Welcome
Sanjay Kulkarni, India
|
0905-0910
|
|
Introduction to SIU-Mostafa M. Elhilali Award Lecture
Sanjay Kulkarni, India
|
0910-0925
|
|
2021 SIU-Mostafa M. Elhilali Award Lecture
|
|
|
2021 Award Winner - Lecture Title: The Butcher, the Baker and the Ice-cream Maker – a Personal Reflection on Prostate Cancer Treatment over the Last Decade
Mark Emberton, United Kingdom
|
0925-0940
|
|
Emirates Urological Society (EUS) Lecture: Oxidative Stress and Male Infertility
Hussein Kandil, United Arab Emirates
Learning Objectives: At the end of Dr. Kandil's lecture, attendees will be able to:
- Explain that nearly 30-80% of infertile males produce high levels of reactive oxygen species (ROS), hence, oxidative stress evaluation remains crucial in the management of male infertility
- Understand the link between oxidative stress and male fertility potential
- Highlight on the term Male Oxidative Stress Infertility (MOSI)
- Understand the way oxidative stress is measured using the most up-to-date available tools with emphasis on the MiOXSYS method of measuring oxidation-reduction potential (ORP)
|
0940-0955
|
|
Pan African Urological Association (PAUSA) Lecture: Challenges and Opportunities in Urethral Reconstruction in Sub Saharan Africa
Mohamed Jalloh, Senegal
Learning Objectives: At the end of Dr. Jalloh's lecture, attendees will be able to:
- Understand the recent progress in the management of urethral stricture in Sub Saharan Africa
- Present the limitation in the management of urethral stricture in Sub Saharan Africa
- Learn possible ways of improving the management of urethral stricture in Sub Saharan Africa
|
0955-1010
|
|
State-of-the-Art Lecture: Genetics of Bladder Cancer
Seth Lerner, United States
Learning Objectives: At the end of Dr. Lerner's lecture, attendees will be able to:
- Apply genomic alterations to risk stratification of non-muscle invasive bladder cancer
- Interpret the key findings of the TCGA project in muscle invasive bladder cancer (MIBC)
- Describe translational opportunities and examples from multiomic profiling of MIBC
- Understand genomic predictors of response to chemotherapy and immunotherapy
|
1010-1025
|
|
State-of-the-Art Lecture: Novel Therapies in RCC and the Impact on Surgery
Peter Mulders, The Netherlands
|
1025-1040
|
|
Late Breaking Abstract Presentation: 3-Year Results from the ROBUST I Study of the Optilume DCB
Sean P. Elliott, United States
|
|
1045-1115
|
|
Break
Room: Sheikh Rashid E
|
1045-1245
|
|
TIPS-02: SIU Tips and Tricks Session - SIU uCare
Room: Dubai AB
Chair: Laurence Klotz, Canada
|
1045-1050
|
|
Welcome and Introduction
Laurence Klotz, Canada
|
1050-1100
|
|
Learnings from the Stent Registry Study
Joyce Baard, The Netherlands
|
1100-1110
|
|
Opportunities and Challenges in China
Rui Chen, China
|
1110-1120
|
|
Barriers and Enablers in Research in South Africa
André van der Merwe, South Africa
|
1120-1130
|
|
Opportunities and Challenges in Taiwan
Jeff S. Chueh, Taiwan
|
1130-1140
|
|
Opportunities and Challenges in Malaysia
Teng Aik Ong, Malaysia
|
1140-1150
|
|
Opportunities for International BPH Studies
Mihir Desai, United States
|
1150-1200
|
|
Opportunities and Challenges in the Emirates
Yasser Farahat, United Arab Emirates
|
1200-1210
|
|
Opportunities and Challenges in Kenya
Patrick Mburugu, Kenya
|
1210-1220
|
|
Opportunities and Challenges in Greece
Athanasios (Thanos) Papatsoris, Greece
|
1220-1225
|
|
Opportunities and Challenges in Iran
M. Hadi Radfar, Iran
|
1225-1230
|
|
The BPH/App uCare Study: An Update
Stavros Gravas, Cyprus
|
1230-1240
|
|
Nested Randomized Trials: A Novel Opportunity for Registry Studies
Laurence Klotz, Canada
|
1240-1245
|
|
Closing Remarks
Laurence Klotz, Canada
|
|
1115-1245
|
|
HT-01: Hot Topics 01 - Harnessing Artificial Intelligence (AI) in Urology
Room: Dubai CD
Chair: Quoc-Dien Trinh, United States
|
|
Learning Objectives: At the end of this session, attendees will be able to:
- Understand the fundamental theory and technical considerations behind the use of artificial intelligence in urology.
- Describe real-world clinical applications of artificial intelligence in urology.
- Understand the ethical and legal considerations surrounding the use of artificial intelligence in urology.
|
|
1115-1245
|
|
HT-02: Hot Topics 02 - PSMA Theranostics
Room: Ras Al Khaimah
Co-Chairs: Tobias Maurer, Germany / Robert Reiter, United States
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Understand the benefit and limitations of staging with PSMA PET in newly diagnosed prostate cancer
- Estimate the role of PSMA-guided salvage surgery and identify suitable patients
- Understand the indication and outcomes of targeted radiotherapy in oligometastatic prostate cancer
- Estimate the value of PSMA PET in the mCRPC setting and the role of PSMA-radioligand therapy
|
|
1115-1245
|
|
IC-03: Instructional Course 03 - Imaging-Guided Biopsy Diagnostic Pathway in Prostate Cancer
Room: Abu Dhabi B
Co-Chairs: Peter Black, Canada / Marc Dall'Era, United States
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Understand risk stratification of prostate lesions on MRI using Prostate Imaging Reporting & Data System (PI-RADS)
- Review the clinical trial data evaluating the role of prostate MRI prior to prostate biopsy
- Learn the steps to establish an image-guided biopsy programme
- Understand how novel imaging such as high-resolution US may be incorporate into the prostate cancer screening pathway
- Understand the limitations of MRI for prostate cancer detection and ‘best practices’ on when and how to perform prostate biopsy in the setting of a negative MRI
|
1115-1127
|
|
Interpreting Multiparametric MRI
Pieter De Visschere, Belgium
|
1127-1130
|
|
Q&A
Pieter De Visschere, Belgium
|
1130-1142
|
|
What is the Evidence for MRI in the Diagnostic Pathway of Prostate Cancer?
Caroline Moore, United Kingdom
|
1142-1145
|
|
Q&A
Caroline Moore, United Kingdom
|
1145-1157
|
|
Establishing an Image-Guided Biopsy Program
Marc Dall'Era, United States
|
1157-1200
|
|
Q&A
Marc Dall'Era, United States
|
1200-1230
|
|
Clinical Dilemmas: Case-Based Panel Discussion
Moderator: Peter Black, Canada Panelists Marc Dall'Era, United States Pieter De Visschere, Belgium Caroline Moore, United Kingdom
|
1230-1245
|
|
Q&A
Moderator: Peter Black, Canada Panelists Marc Dall'Era, United States Pieter De Visschere, Belgium Caroline Moore, United Kingdom
|
|
1115-1245
|
|
IC-04: Instructional Course 04 - Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Room: Abu Dhabi A
Chair: Dean Elterman, Canada
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the mechanism of action and technique for each of the novel BPH therapies
- Select the best patients for each procedure type based upon patient and prostate characteristics
- Gain knowledge of the clinical data supporting the use of each modality
- Understand best-practice technique for each modality based upon the literature and expert opinion
- Gain an appreciation for the challenges encountered and troubleshooting for each technology
- Appreciate the “tips & tricks” provided by the experts for performing these novel BPH therapies
|
1115-1120
|
|
Introduction to Novel BPH Therapies
Dean Elterman, Canada
|
1120-1132
|
|
Laser Transurethral Endoscopic Enucleation of the Prostate (EEP)
Vincent Misrai, France
|
1132-1136
|
|
Q&A
Vincent Misrai, France
|
1136-1148
|
|
UroLift
Dean Elterman, Canada
|
1148-1152
|
|
Q&A
Dean Elterman, Canada
|
1152-1204
|
|
Rezum
Vineet Gauhar, Singapore
|
1204-1208
|
|
Q&A
Vineet Gauhar, Singapore
|
1208-1220
|
|
Aquablation
Enrique Rijo, Spain
|
1220-1224
|
|
Q&A
Enrique Rijo, Spain
|
1224-1236
|
|
Stents
Dean Elterman, Canada
|
1236-1240
|
|
Q&A
Dean Elterman, Canada
|
1240-1245
|
|
Closing Remarks
Dean Elterman, Canada
|
|
1115-1245
|
|
JS-01: Joint SIU-Endourological Society Session
Room: Sheikh Maktoum D
Chair: Mahesh R. Desai, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand technical details of some challenging aspects of complex surgeries
- Understand the newer developments in areas of focal therapy for renal tumors and ureteral stents
- Learn all controversies about SWL, holmium laser and newer modalities of BPH treatment
- Gain knowledge of future developments and technical details of various endourological procedures
|
1115-1120
|
|
Introduction
Mahesh R. Desai, India
|
|
|
Session 1: How I Do It – Tips & Tricks, Technique Videos
|
1120-1126
|
|
Nerve Sparing in Radical Prostatectomy
Ashutosh Tewari, United States
|
1126-1132
|
|
IVC Incision in Level 1 IVC Thrombus Rt Robotic Radical Nephrectomy
Mihir Desai, United States
|
1132-1138
|
|
Treatment of Upper Tract TCC by FURS - Key Points for Success
Michael Grasso, United States
|
1138-1144
|
|
ThuLEP - Why I Prefer it
Thomas Herrmann, Switzerland
|
1144-1150
|
|
Treatment of Lower Calyx Stone by RIRS
Thimme Gowda Manohar, India
|
1150-1156
|
|
ECIRS – Key Points for Success
Vineet Gauhar, Singapore
|
|
|
Session 2: State-of-the-Art Lectures
|
1156-1203
|
|
Focal Therapy for Renal Tumors
Pilar Laguna, Türkiye
|
1203-1210
|
|
Ureteral Stent – What is the Future?
Ravi Kulkarni, United Kingdom
|
|
|
Session 3 – Debate
|
1210-1224
|
|
Is SWL Out of the Armamentarium of Modern Urology
|
|
|
Yes
Jean de la Rosette, Türkiye
|
|
|
No
Arun Chawla, India
|
1224-1238
|
|
Holmium Laser for Stone is on Death Bed
|
|
|
Yes
Olivier Traxer, France
|
|
|
No
Khurshid Ghani, United States
|
1238-1245
|
|
Closing Remarks
Mahesh R. Desai, India
|
|
1115-1245
|
|
MP-01: Moderated ePoster Session 01 - Bladder Cancer
Room: Sharjah D
Moderators: Tamer A. Abouelgreed, Egypt / Saeed R. Samnakay, Kenya
|
1115-1245
|
|
ePoster Presentation
Jean de la Rosette, Türkiye Milan Kral, Czech Republic
Presenters Suleiman Abuhasanein, Sweden Abbas Basiri, Iran Peter Black, Canada Rahim Horuz, Türkiye Shanmugasigamani Kannan, United Kingdom Ernest Kimani, Kenya Anil Kumar T, India Kishore Raja, United Kingdom Utsav Shailesh Shah, India Prashant Singh, India
|
|
1115-1245
|
|
MP-02: Moderated ePoster Session 02 - Pediatrics/ Miscellaneous/ Basic Science
Room: Umm Al Quwain
Moderators: Brian Birch, United Kingdom / Noor Buchholz, United Arab Emirates
|
1115-1245
|
|
ePoster Presentation
Presenters Tariq Ahmad, Pakistan Ahmed Mohamed Nabil Ahmed Sakr, Egypt Liaqat Ali, Pakistan Nordine Amara, France Anas Abdel Basit, United Kingdom Achraf Chatar, Morocco Jorge Correia, Portugal Dean Elterman, Canada Sakineh Hajebrahimi, Iran Abheesh Hegde, India Kingsley Igbojionu, United Kingdom Salma Awad Merghani Mahmoud, United Arab Emirates Romy Mondschein, Australia Truong Thanh Do, Vietnam Arndt van Ophoven, Germany Shaun E.L. Wason, United States
|
|
1115-1255
|
|
JS-02: Joint SIU-International Society of Reconstructive Urology (ISORU) Session
Room: Sheikh Rashid A
Co-Chairs: Reynaldo Gómez, Chile / Sanjay Kulkarni, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Distinguish the different types of hypospadias repair and develop a simplified management plan
- Distinguish the difference in management options of radiation induced strictures
- Recognize the latest concepts in transgender surgery
- Determine the technique to preserve bulbar arteries in anastomotic urethroplasty
- Evaluate complex stricture and plan the appropriate management
|
1115-1118
|
|
Introduction
Reynaldo Gómez, Chile Sanjay Kulkarni, India
|
1118-1133
|
|
Hypospadias Surgery
Miroslav Djordjevic, Serbia
|
1133-1148
|
|
Radiation and Urethral Problems
Anthony Mundy, United Kingdom
|
1148-1203
|
|
Gender Reassignment
Richard Santucci, United States
|
1203-1213
|
|
Vaginoplasty: Preparation, Surgical Anatomy, Follow-up, Oncological Considerations
Daniel Dugi, United States
|
1213-1228
|
|
Vessel Sparing Posterior Urethroplasty
Reynaldo Gómez, Chile
|
1228-1243
|
|
Complex Urethroplasty
Sanjay Kulkarni, India
|
1243-1245
|
|
Ask the Experts
Panelists Reynaldo Gómez, Chile Sanjay Kulkarni, India Richard Santucci, United States
|
|
1245-1315
|
|
SYMP-21: Luncheon Symposium: Focal HIFU Therapy in Prostate Cancer: Practice Changes on the Horizon?
Room: Sheikh Maktoum BC
Chair: Rafael Sanchez-Salas, Canada Moderator: Franck Bladou, France Faculty: Pascal Rischmann, France / Martin Schostak, Germany
|
|
At the end of this session, attendees will be able to:
- Review the current implementation of focal HIFU therapy for localized prostate cancer, with a focus on differences in HIFU adoption in different countries.
- Examine alternative focal therapy approaches currently used in the clinical practice to manage localized disease.
- Analyze advances in HIFU technology and their impact on treatment decision-making, with emphasis on oncologic control and patient quality of life.
- Discuss current challenges limiting the adoption of focal HIFU therapy in the clinical practice, including differences in guideline recommendations.
|
|
1245-1415
|
|
Lunch Break
Room: Sheikh Rashid E
|
1400-1700
|
|
SYMP-20: Emirates Urological Society (EUS) Programme
Room: Sheikh Rashid CDF
Co-Chairs: Abdulqadir Alzarooni, United Arab Emirates / Yasser Farahat, United Arab Emirates
|
1400-1405
|
|
Welcome Remarks
Abdulqadir Alzarooni, United Arab Emirates Jean de la Rosette, Türkiye Yasser Farahat, United Arab Emirates
|
|
|
Part 1 - Miniaturization in Endourology
|
1405-1415
|
|
Miniaturization in PCNL: CON
Noor Buchholz, United Arab Emirates
|
1415-1425
|
|
Miniaturization in PCNL: PRO
Sanjay Khadgi, Nepal
|
1425-1435
|
|
Miniaturization in FURS: Is it The Way to Go?
Saeed Bin Hamri, Saudi Arabia
|
1435-1445
|
|
Miniaturization in Stone Fragments: Is Dusting the Best Choice?
Rabii Madi, United Arab Emirates
|
1445-1450
|
|
Expert Comments
Iyad Emad, United Arab Emirates Jean de la Rosette, Türkiye Yasser Farahat, United Arab Emirates
|
|
|
Part 2 - Men's Health Current and Future Challenges
|
1450-1500
|
|
COVID 19 & Sexual Dysfunction: The Untold Story
Vipan Bhatia, United Arab Emirates
|
1500-1510
|
|
Updates in the Management of ED & BPH/LUTS
Muhammad Bulbul, Lebanon
|
1510-1520
|
|
Anatomical Considerations of IPP Placement: Pitfalls you Can Avoid
Daniar Osmonov, Germany
|
1520-1530
|
|
Penile Lengthening Strategies at Time of IPP
Steven Wilson, United States
|
1530-1535
|
|
Expert Comments
Manaf Al Hashimi, United Arab Emirates Mohamed Elkhouly, United Arab Emirates Abdulqadir Alzarooni, United Arab Emirates
|
|
|
Part 3 - BPH/LUTS: Best Clinical Practice
|
1535-1545
|
|
Recent Recommendation in the Management of Male LUTS
Stavros Gravas, Cyprus
|
1545-1555
|
|
MIST of BPH
Dean Elterman, Canada
|
1555-1605
|
|
Echolaser Transperineal Ablation of the Prostate in Outpatient Setting
Alessandro Bertaccini, Italy Debora Marchiori, Italy
|
1605-1615
|
|
Post Prostatectomy ED/ incontinence: Surgical Tips & Tricks
Valentin Pavlov, Russia
|
1615-1620
|
|
Expert Comments
Wael Toson Abdelsalam, United Arab Emirates Mohsen Elmekresh, United Arab Emirates Yaser Saeedi, United Arab Emirates
|
|
|
Part 4 - Updates in Prostate Cancer
|
1620-1630
|
|
MRI Imaging of Prostate in Clinical Practice
Waleed Hassen, United Arab Emirates
|
1630-1640
|
|
PET Scanning in Prostate Cancer: Current Recommendation(s)
Hidayath Ansari, United Arab Emirates
|
1640-1650
|
|
Patient Selection for Focal Therapy
Laurence Klotz, Canada
|
1650-1700
|
|
Management Updates in mHSPC
Jawaher Ansari, United Arab Emirates
|
1700-1705
|
|
Expert Comments
Hosam Al-Qudah, United Arab Emirates Ali Thwaini, United Arab Emirates Waleed Hassen, United Arab Emirates
|
1705-1710
|
|
Closing Remarks
Abdulqadir Alzarooni, United Arab Emirates Yasser Farahat, United Arab Emirates
|
|
1415-1545
|
|
IC-06: Instructional Course 06 - Minimally-Invasive PCNL (Mini-PCNL): The Way Forward
Room: Abu Dhabi A
Chair: Madhu Sudan Agrawal, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Guide participant about how to perform successful puncture in PCNL by own self, using ultrasound and fluoroscopy for access, singly or in combination (rather than being dependent on the radiologist for obtaining access)
- Understand the steps of mini-PCNL procedure, including single-step tract dilatation, use of mini-nephroscope, and the principle of ‘vacuum-cleaner effect for retrieval of fragments
- Employ different energy sources for stone fragmentation including high-power laser, and use of different exit strategies, as explained during the course
- Apply knowledge of minimally-invasive PCNL in their own practice to improve the patient outcomes in terms of reduced morbidity
|
|
1415-1545
|
|
IC-07: Instructional Course 07 - Focal Therapy for Locoregional or Oligometastatic Recurrence of Prostate Cancer
Room: Dubai CD
Chair: Pierre Blanchard, France
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Define oligometastatic disease and recurrence in Prostate Cancer
- Understand how to select patients for eventual ablative treatment: Biomarkers and Imaging
- Understand the role of Systemic therapies
- Understand the role Radiotherapy
- Understand the role of Surgical Treatment
- Understand the role of Focal Therapy
|
|
1415-1545
|
|
MV-01: Master Videos 01 - Genitourinary Fistulae
Room: Sheikh Rashid A
Co-Chairs: Sherif Mourad, Egypt / Shrawan Kumar Singh, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the concept and physiopathology of “different types of fistulae”
- Identify and select the proper management and approach of fistula repair
- Diagnose and indicate the adequate management of complicated vesicovaginal fistula
|
|
1415-1545
|
|
MP-03: Moderated ePoster Session 03 - Infections & Inflammatory Disease
Room: Dubai AB
Moderators: Mohsen Elmekresh, United Arab Emirates / Rajeev T P, India
|
|
1415-1545
|
|
MVP-01: Moderated Video Session 01 - BTO/LUTS, Miscellaneous, Pediatric Urology, Reconstruction
Room: Sharjah D
Moderators: Hamdy Abotaleb, United Arab Emirates / Rizwan Hamid, United Kingdom
|
|
1415-1715
|
|
INN: SIU Innovators' Symposium
Room: Sheikh Maktoum D
Co-Chairs: Renu Eapen, Australia / Maria Carmen Mir, Spain
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Improve telemedicine skills during encounters to optimize outcomes.
- Gain a broader knowledge on available EMR platforms (pros and cons)
- Understand reimbursement issue related to telemedicine
- Recognize health policy and regulations within different countriesImprove knowledge on current mentoring options and facilitation of networking for surgical/medical skills improvement
- Define state of the art status on gender disparities across geographic areas
- Facilitate establishment of mentorship programmes within urology societies
- Dissect regulatory rules to facilitate in establishment of new drug treatments
|
1415-1500
|
|
Part 1: Telemedicine
Moderator: Evanguelos Xylinas, France
At the end of this session, attendees will be able to:
- Improve telemedicine skills during encounters to optimize outcomes.
- Gain a broader knowledge on available EMR platforms (pros and cons)
- Understand reimbursement issue related to telemedicine
- Recognize health policy and regulations within different countries
|
1415-1420
|
|
How to Have a Successful Telemedicine Encounter
Emmanuel Abara, Canada
|
1420-1425
|
|
Remote Patient Monitoring- How to Optimize Follow-up Strategies in Urology (Oncology vs Non-oncology)
Jonathan Makanjuola, United Kingdom
|
1425-1430
|
|
Current Apps Available on The Market and How to Optimize Them
Jonathan Makanjuola, United Kingdom
|
1430-1435
|
|
Q&A
Jonathan Makanjuola, United Kingdom
|
1435-1445
|
|
Debate on EMR vs Taditional Paper Charts
|
|
|
For Paper Charts
Sophie Rintoul-Hoad, United Kingdom
|
|
|
For EMR
Matthew Cooperberg, United States
|
|
|
Discussion
|
1500-1545
|
|
Part 2: Telementoring
Moderators Mélanie Aubé-Peterkin, Canada Dean Elterman, Canada
At the end of this session, attendees will be able to:
Improve knowledge on current mentoring options and facilitation of networking for surgical/medical skills improvement |
1500-1520
|
|
Current Platforms for Life Surgical Mentoring. Why Should we Promote Telementoring? Pros and Cons
Nadine Hachach-Haram, United Kingdom
|
1520-1540
|
|
Real-Life Experience on Urology Telementoring - What to Expect?
Ben Challacombe, United Kingdom James Porter, United States
|
1540-1545
|
|
Q&A
|
1545-1600
|
|
Break
|
1600-1630
|
|
Part 3: Urology Equity - You Cannot Be What You Cannot See: Promoting Equity in Surgery
Moderator: Maria Carmen Mir, Spain
At the end of this session, attendees will be able to:
- Define state of the art status on gender disparities across geographic areas
- Facilitate establishment of mentorship programmes within urology societies
|
1600-1612
|
|
Current Status of Gender Equity per Continent. Current Analysis as per EAU/SIU/AUA Membership Office
Tamsin Greenwell, United Kingdom
|
1612-1625
|
|
Academic Opportunities: Establishing Mentorship Programmes to Promote Equity
Anne P. Cameron, United States
|
1625-1630
|
|
Q&A
|
1630-1715
|
|
Part 4: Planning Clinical Trials
Moderator: Evanguelos Xylinas, France
|
1630-1645
|
|
How to Set up a Primary Endpoint for a Clinical Trial in Oncology/Non-Oncology
Sabine Brookman-May, Germany
|
1645-1700
|
|
How to Introduce New Drug/Surgical Treatments in Asia
Jeremy Yuen-Chun Teoh, Hong Kong
|
1700-1715
|
|
Strategies to Obtain FDA/EMA Approval: Rationale for Trial Design
Petros Grivas, United States
|
|
1545-1615
|
|
Break
Room: Sheikh Rashid E
|
1615-1745
|
|
IC-08: Instructional Course 08 - Case Based Discussions in Neuro-urology
Room: Ras Al Khaimah
Chair: Rizwan Hamid, United Kingdom
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Understand the management principles in Neurourology
- Appreciate the differences in managing various neuro-urological conditions
- Gain confidence in tacking neurourological problems
- Understand the recommendations in International neuro-urological guidelines
- Formulate a management plan for a neuro-urological patient
|
|
1615-1745
|
|
IC-09: Instructional Course 09 - Complex Penile and Urethral Reconstruction in Adults with Prior Hypospadias or Epispadias
Room: Dubai CD
Co-Chairs: Marta Bizic, Serbia / Jairam Eswara, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
-
Define modalities of hypospadias surgery in adult patients
-
Recognize complications of hypospadias treatment and different surgical approaches for their resolution
-
Recognize most important surgical steps in re-do epispadias repair; define and achieve successful outcome
-
Recognize penile curvature in adults as a consequence of Peyronie's disease or congenital deformity
-
Conduct good postoperative care and treatment.
|
1615-1620
|
|
Introduction
Marta Bizic, Serbia Jairam Eswara, United States
|
1620-1635
|
|
Hypospadias in Adults - Primary Repair
Marta Bizic, Serbia
|
1635-1650
|
|
Late Complication of Hypospadias
Alaa El Ghoneimi, France
|
1650-1705
|
|
Re-Doing Epispadias After Failed Surgery in Childhood
Miroslav Djordjevic, Serbia
|
1705-1720
|
|
Penile Curvature in Adults: Peyronie’s Disease or Congenital?
Cooper Benson, United States
|
1720-1730
|
|
Phalloplasty: Preparation, Surgical Anatomy, Prosthetics, Follow-up
Richard Santucci, United States
|
1730-1740
|
|
Q&A and Discussion
Marta Bizic, Serbia Jairam Eswara, United States
|
1740-1745
|
|
Conclusions
Marta Bizic, Serbia Jairam Eswara, United States
|
|
1615-1745
|
|
MV-02: Master Videos 02 - Endoscopic Surgery for BPH: Compare and Contrast
Room: Sheikh Rashid A
Co-Chairs: Athanasios (Thanos) Papatsoris, Greece / Anil Kumar Varshney, India
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Discuss the place of endoscopic surgeries in the overall management of BPH
- Compare various indications, contraindications, technical details and know how to do these procedures
- Learn where they can go wrong and how to minimize complications
- Gain tips to provide better outcomes
- Understand the limitations and scenarios when not to do these operations
- Highlight efficacy parameters, safety concerns, durability, versatility, cost-effectiveness, learning and mentoring
|
1615-1630
|
|
Aquablation
Vincent Misrai, France
|
1630-1645
|
|
Urolift: Minimally Invasive Surgical Procedures for LUTS due to BPO: Focus on PUL
Mauro Gacci, Italy
|
1645-1700
|
|
Various Endoscopic Enucleation Procedures in Europe
Javier Sanchez Macias, Spain
|
1700-1715
|
|
Enucleation by Holmium Laser (HoLEP)
Anil Kumar Varshney, India
|
1715-1730
|
|
BipolEP
Athanasios (Thanos) Papatsoris, Greece Dimitrios Staios, Greece
|
1730-1740
|
|
Q&A + Panel Discussion
Mauro Gacci, Italy Javier Sanchez Macias, Spain Vincent Misrai, France Athanasios (Thanos) Papatsoris, Greece Dimitrios Staios, Greece Anil Kumar Varshney, India
|
1740-1745
|
|
Take‐home Message
Athanasios (Thanos) Papatsoris, Greece Anil Kumar Varshney, India
|
|
1615-1750
|
|
IS-01: Interactive Session 01 - Open Surgery in 2021: When and Why?
Room: Abu Dhabi B
Co-Chairs: Hassan Abol-Enein, Egypt / Amlesh Seth, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Gain knowledge of open surgery in bladder cancer and renal cell carcinoma (RCC)
- Understand how open retroperitoneal lymph node dissection (RPLND) is conducted in testicular cancer
- Understand the applications of Trans-perineal Radical Prostatectomy in prostate cancer
|
1615-1620
|
|
Introduction
Hassan Abol-Enein, Egypt Amlesh Seth, India
|
1620-1635
|
|
Open Surgery in Bladder Cancer
Hassan Abol-Enein, Egypt
|
1635-1642
|
|
Case Discussion 1 (with Audience Participation) Bladder Cancer
Hassan Abol-Enein, Egypt
|
1642-1657
|
|
Open Retroperitoneal Lymph Node Dissection (RPLND)
Amlesh Seth, India
|
1657-1704
|
|
Case Discussion 2 (with Audience Participation) Testicular Cancer
Amlesh Seth, India
|
1704-1719
|
|
Open Surgery in Renal Cell Carcinoma (RCC)
Fernando Secin, USA
|
1719-1726
|
|
Case Discussion 3 (with Audience Participation) Kidney Cancer
Fernando Secin, USA
|
1726-1741
|
|
Trans-perineal Radical Prostatectomy
Selami Albayrak, Türkiye
|
1741-1748
|
|
Case Discussion 4 (with Audience Participation) Prostate Cancer
Selami Albayrak, Türkiye
|
1748-1750
|
|
Closing Remarks
Hassan Abol-Enein, Egypt Amlesh Seth, India
|
|
Saturday, November 13
Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.
0700-0800
|
|
GA: General Assembly
Room: Abu Dhabi B
|
0730-0900
|
|
IC-11: Instructional Course 11 - Bleeding Complications of PCNL - Prevention & Management
Room: Ras Al Khaimah
Chair: Ravindra Sabnis, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the cause of bleeding
- Explain when, why and at which steps, bleeding occurs while doing PCNL
- Identify the cause of post PCNL bleeding
- Understand how to manage bleeding once it occurs
- Determine the steps to be taken to prevent bleeding
|
0730-0735
|
|
Introduction
Ravindra Sabnis, India
|
0735-0750
|
|
Etiological Factors Leading to Bleeding Complication – Pre, Intra & Post-op
Ravindra Sabnis, India
|
0750-0805
|
|
Intra-op Excessive Bleeding – How to Tackle
Michael Borofsky, United States
|
0805-0820
|
|
Post-op Bleeding – Step-by-Step Management
Brian Matlaga, United States
|
0820-0835
|
|
Preventing Steps to Reduce Bleeding Complications in PCNL
Jean de la Rosette, Türkiye
|
0835-0900
|
|
Case-Based Discussion
Moderator: Ravindra Sabnis, India Panelists Michael Borofsky, United States Jean de la Rosette, Türkiye Brian Matlaga, United States
|
|
0730-0900
|
|
IC-12: Instructional Course 12 - Tools to Make Caring for Pelvic Pain Easier and More Successful for the Urologist
Room: Umm Al Quwain
Chair: Elise De, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Explain differential diagnosis for causes of pelvic pain
- Determine what to try first, what not to miss, and what to do next
- Evaluate associated conditions – signs of systemic etiology and how to approach
|
|
0730-0900
|
|
IC-13: Instructional Course 13 - PDE 5 Inhibitor Non-Responders for Erectile Dysfunction
Room: Sheikh Maktoum D
Chair: Vipan Bhatia, United Arab Emirates
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Define PDE 5 inhibitor non responders and incidence and avoid over-diagnosis
- Identify causes, need for proper history taking, Investigations, testosterone deficiency, couple therapy
- Explain combination medical therapy with multiple PDE 5 inhibitors and testosterone supplementation
- State the role of minimally invasive therapy including penile shock wave therapy and platelet rich therapy
- Discuss future therapies on the horizon - gene and stem cell therapy
- Recognize practical guidelines
|
|
0800-0900
|
|
MC-03: Master Class 03 - Geriatric Urology
Room: Abu Dhabi A
Co-Chairs: Narmada P. Gupta, India / Sanjay Sinha, India
|
|
Learning Objectives: At the end of this session, attendees will be able to:
- Evaluate patients for pre-operative frailty, with an understanding of risk stratification and its implications
- Understand urogenital problems after menopause, i.e., the effects of oestrogen replacement
- Gain knowledge of Detrusor underactivity in aging patients (evaluation and management)
- Apply knowledge of bladder outlet obstruction in frail elderly patients, with expert tips on approach to management
|
|
0800-1615
|
|
NURS: 6th SIU Global Nurses' Educational Symposium
Room: Dubai CD
Co-Chairs: Hussam Al Nusair, United Arab Emirates / Amparo Gudrun Camacho, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Review diagnosis and surgical treatment for bladder cancer
- Discuss ostomy care interventions
- Discuss ERAS protocol basics
- Establish erectile dysfunction treatment compliance in men with prostate cancer and how this affects their recovery
- Determine infection control interventions for penile prosthesis
- Describe the causes and treatment of lower urinary tract dysfunction, including the newest therapies for prostate enlargement
- Consider voiding dysfunction interventions and the use of intermittent catheterization
- Evaluate the role of imaging and novel biomarkers in the treatment of patients with prostate cancer on active surveillance
- Describe nursing considerations when conducting prostate biopsies
- Detail urodynamic testing setup and its interpretation
- Review neuromodulation as treatment modality in voiding dysfunction
- Detail surgical approaches to urinary stone disease
- Describe operating room settings for stone surgery and laser safety
- Define treatment of urosepsis and the use of skin cleansers during Foley catheter insertions
- Discuss skincare considerations for patients with wounds and dermatitis
|
0800-0805
|
|
Welcome
Hussam Al Nusair, United Arab Emirates Amparo Gudrun Camacho, United States
|
0805-0830
|
|
Diagnosis and Treatment of Bladder Cancer
Waleed Hassen, United Arab Emirates
|
0830-0850
|
|
Ostomy Management
Vashti Livingston, United States
|
0850-0910
|
|
ERAS: Enhanced Recovery After Surgery
Corey Weinstein, United States
|
0910-0935
|
|
Compliance with Erectile Dysfunction Treatment in Men with Prostate Cancer
Christian Nelson, United States
|
0935-1000
|
|
Case Study and Clinicians’ Experiences: Nursing Support for Patients with Sexual Dysfunction
Samantha Strumeier, United States
|
1000-1015
|
|
Infection Control for Penile Implantation
Monica Chan, United Arab Emirates
|
1015-1030
|
|
Break
|
1030-1055
|
|
BPH/LUTS Treatment
Jaspreet S. Sandhu, United States
|
1055-1105
|
|
Nursing Considerations for Patients with Urinary Symptoms
Lydia Nahorniak, United States
|
1105-1115
|
|
Nursing Practice Related to Intermittent Catheterization Evidence-Based Practice
Marcerey Sison Quejada, United Arab Emirates
|
1115-1120
|
|
Q&A
Lydia Nahorniak, United States Marcerey Sison Quejada, United Arab Emirates
|
1120-1135
|
|
Abstract Presentations
Moderators Amparo Gudrun Camacho, United States Mariezl Fonbuena, United Arab Emirates
|
1135-1150
|
|
Case Study: Prostate Cancer Patient Care
Amparo Gudrun Camacho, United States
|
1150-1250
|
|
Break
|
1250-1315
|
|
The Role of Imaging and Novel Biomarkers to Guide Active Surveillance
Behfar Ehdaie, United States
|
1315-1340
|
|
Considerations When Performing Prostate Biopsies
Kenny (Xin) Lin, United States
|
1340-1350
|
|
Urodynamic Setup
Abigail Rome Bibe, United Arab Emirates
|
1350-1400
|
|
Interpretation and Artifacts
Dean Elterman, Canada
|
1400-1410
|
|
Neuromodulation
Dean Elterman, Canada
|
1410-1415
|
|
Q&A
Dean Elterman, Canada
|
1415-1440
|
|
Therapeutic Modalities and Management of Complex Stone Disease
Daniel Pérez-Fentes, Spain
|
1440-1455
|
|
Operating Room Settings for Stone Surgery (PCNL, Ureteroscopy with Lithotripsy)
Rogelio Silverio, United Arab Emirates
|
1455-1510
|
|
Laser Safety in Surgery – General Safety and Specific Requirements in OT
Rogelio Silverio, United Arab Emirates
|
1510-1535
|
|
Urosepsis
Sondos Jarrad, United Arab Emirates
|
1535-1545
|
|
Use of Chlorhexidine 0.1% for Urethral Cleaning in Pre- and Post- Foley’s Catheter Insertion (Evidence-Based Practice)
Marcerey Sison Quejada, United Arab Emirates
|
1545-1555
|
|
Structuring Skin Care to Prevent Incontinence Associated Dermatitis
Marilou Mendoza-Manarang, United Arab Emirates
|
1555-1605
|
|
Comparative Study of Incontinence Associated Dermatitis Treatments- (Evidence-based practice)
Marilou Mendoza-Manarang, United Arab Emirates
|
1605-1610
|
|
Q&A
Marilou Mendoza-Manarang, United Arab Emirates Marcerey Sison Quejada, United Arab Emirates
|
1610-1615
|
|
Meeting Close and Invitation to 7th SIU Global Nurses' Educational Symposium
Hussam Al Nusair, United Arab Emirates Amparo Gudrun Camacho, United States
|
|
0900-1030
|
|
DEMO: Demo Session: Tips and Tricks in fURS
Room: Abu Dhabi B
Chair: Wissam Kamal, Saudi Arabia Faculty: Mudhar Nazar Hasan, United Arab Emirates
|
|
Pre-registration is required for this session
This session will focus more on endourological procedures (RIRS and PCNL) in terms of instrumentation, technique and tips and tricks.
Learning Objectives
- Assess indications of each technique (PCNL and RIRS)
- Compare instrumentation for each technique (disposable vs. reusable equipment)
- Recognize the basics of endoscope manipulation and laser applications
- Understand the principles of management of endourological complications
|
|
0900-1045
|
|
PL-02: Plenary 02
Room: Sheikh Rashid CDF
Honorary Chairs: Stavros Gravas, Cyprus / Simon Tanguay, Canada
|
0900-0915
|
|
Welcome and SIU Academy Awards Presentation
|
0915-0930
|
|
State-of-the-Art Lecture: Is it Time to Revisit Prostate Cancer Screening?
Mark Emberton, United Kingdom
Learning Objectives:
At the end of Dr. Emberton's lecture, attendees will be able to:
- Assess the unmet need for a screening programme
- Consider a range of screening interventions
- Appreciate the methodological challenges
- Explore alternative trial designs
|
0930-0945
|
|
State-of-the-Art Lecture: The Role for the General Urologist in the Era of Subspecialization
Ashutosh Tewari, United States
|
0945-1000
|
|
Confederación Americana de Urología (CAU) Lecture: Symptomatic BPH - Present Surgical Options for an Ageing Problem
Alejandro Rodriguez, United States
Learning Objectives: At the end of Dr. Rodríguez's lecture, attendees will be able to:
- Know the different contemporary options available for the surgical management of symptomatic BPH
- Select patients appropriately for the surgical treatment of BPH
- Know the pros and cons of each type of surgical approach
- Know the reported clinical outcomes of each type of surgical approach for BPH
|
1000-1015
|
|
Urological Association of Asia (UAA) Lecture: Technological Evaluation of Renal Puncture for Endoscopic Surgery
Shuzo Hamamoto, Japan
Learning Objectives: At the end of Dr. Hamamoto's lecture, attendees will be able to:
- Detail endourological approaches to urinary stone disease (PCNL and ECIRS)
- Describe image-guided percutaneous access including fluoroscopic and ultrasound-guided puncture
- Discuss the latest technological evolution of renal puncture
|
1015-1045
|
|
Panel on Transitional Urology
Moderator: Sean P. Elliott, United States Faculty Rizwan Hamid, United Kingdom Dan Wood, United States
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Describe the general challenges in lifelong adult care of congenital urologic conditions
- Understand the urologic management of spina bifida in the adult
- Understand the urologic management of exstrophy in the adult
- Describe the options for continent and non-continent diversion in the adult with congenital urologic conditions
|
|
0900-1200
|
|
INN-02: Prostate MRI Reading and Fusion Biopsy Hands On Training Course
Room: Sheikh Rashid B
Co-Chairs: Tristan Barrett, United Kingdom / Christof Kastner, United Kingdom
|
|
At the end of this session, attendees will be able to:
- Recall key features of systematic prostate MRI reading according to PI-RADS standards.
- Read and report basic and intermediate level prostate MR imaging with confidence.
- Recognize the technical features and capabilities of prostate biopsy and fusion technology using MR imaging for targeting.
- Identify the key requirements to safely integrate MR imaging into the prostate diagnostic pathway.
|
0900-0905
|
|
Welcome and Introduction to Prostate Cancer Diagnostics and the Role of MRI
Christof Kastner, United Kingdom
|
0905-1040
|
|
MRI Workshop
Tristan Barrett, United Kingdom
|
0905-0917
|
|
Tutorial: Prostate MRI and PI-RADS
Tristan Barrett, United Kingdom
|
0917-0922
|
|
DynaCAD Introduction (Presented by Philips)
|
0922-0957
|
|
Hands-On: MRI Case Analysis DynaCAD - Basic
Tristan Barrett, United Kingdom
|
0957-1005
|
|
Tutorial: Pearls & Pitfalls of Reading and Reporting
Tristan Barrett, United Kingdom
|
1005-1040
|
|
Hands-On: MRI Case Analysis DynaCAD - Basic-Iterm
Tristan Barrett, United Kingdom
|
1040-1055
|
|
Integration of MRI and Fusion Biopsy into the Diagnostic Pathway
Christof Kastner, United Kingdom
|
1055-1130
|
|
Biopsy Workshop
Christof Kastner, United Kingdom
|
1055-1105
|
|
Tutorial: Biopsies Using Prostate MRI
Christof Kastner, United Kingdom
|
1105-1130
|
|
Live & On-Screen Demo by Industry: Advanced Biopsy Equipment
Christof Kastner, United Kingdom
|
1130-1145
|
|
Value and Use of MRI Based Assessment in Treatment Decision and Surveillance of Prostate Cancer
Jurgen Fütterer, The Netherlands
|
1150-1200
|
|
Discussion and Finish
|
|
1045-1115
|
|
Break
Room: Sheikh Rashid E
|
1115-1245
|
|
HT-03: Hot Topics 03 - Future of Urology - Next 20 Years
Room: Abu Dhabi A
Co-Chairs: Zaki Almallah, United Arab Emirates / Sudhir Rawal, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Describe the impacts of media in our management of patients
- Recognize the importance of educating young doctors on the state-of-the-art techniques, and
- Assess the future direction of urology
|
|
1115-1245
|
|
IC-02: Instructional Course 02 - Orthotopic Reconstruction: How to Improve Outcomes
Room: Umm Al Quwain
Chair: Richard Hautmann, Baden-Württemberg
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand that most surgeons use too small reservoirs. A minimum ileal segment of 50 cm (better 60) is required
- Explain that reservoir shape plays a major role. A U-shaped reservoir has a pressure twice as high as a W-shaped reservoir
- Recall that perfect detutularization is a must. Any tubular segments must be avoided
- Apply cross folding of the reservoir which is a must
- Conclude that a nerve sparing RC will result in superior continence
|
|
1115-1245
|
|
IC-14: Instructional Course 14 - Nuestros Trucos Técnicos en Cirugía Uretral (Course in Spanish) [Our Technical Tricks in Urethral Surgery]
Room: Ras Al Khaimah
Chair: Reynaldo Gómez, Chile
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- See surgical techniques with pearls from experts in the field with an interactive approach
- Understand oral mucosal and other graft harvest and fixation options
- Appreciate how to troubleshoot various reconstructive surgeries and manage (and avoid) common complications
- Learn how to utilize various surgical tools to improve outcomes
|
1115-1120
|
|
Introducción
Reynaldo Gómez, Chile
|
1120-1136
|
|
Trucos y Consejos en Patología de Uretra Femenina
Jessica DeLong, United States
|
1136-1140
|
|
Preguntas y respuestas
Jessica DeLong, United States
|
1140-1156
|
|
Estrecheces Secundarias al Cuff de Esfínter Artificial
Javier Ponce de León, Spain
|
1156-1200
|
|
Preguntas y respuestas
Javier Ponce de León, Spain
|
1200-1216
|
|
Trucos y Consejos Para la Reconstrucción de Uretra Bulbar
Leandro Capiel, Argentina
|
1216-1220
|
|
Preguntas y respuestas
Leandro Capiel, Argentina
|
1220-1236
|
|
Técnicas de Pubectomía para Reconstrucción de Uretra Posterior
Reynaldo Gómez, Chile
|
1236-1240
|
|
Preguntas y respuestas
Reynaldo Gómez, Chile
|
1240-1245
|
|
Comentarios finales
Reynaldo Gómez, Chile
|
|
1115-1245
|
|
JS-03: Joint SIU-International Continence Society (ICS) Session
Room: Sheikh Rashid A
Co-Chairs: David Manuel Castro Díaz, Spain / Sherif Mourad, Egypt
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the concept and physiopathology of “complex SUI in women”
- Identify and select the proper management of mixed urinary incontinence
- Diagnose and indicate the adequate management of intrinsic sphincter dysfunction, recurrent SUI, neurogenic SUI as well as concurrent vesicovaginal fistula or urethral diverticula in women with stress urinary incontinence
|
|
1245-1415
|
|
SYMP-22: Luncheon Symposium: Immunotherapy in MIUC: Current Practices and Future Perspectives
Room: Sheikh Maktoum BC
Chair: James Catto, United Kingdom Moderator: Peter Black, Canada
|
|
At the end of this session, attendees will be able to:
- Review the most recent guidelines for MIUC
- Examine current challenges and opportunities for improving patient outcomes
- Review the potential role of immunotherapy in MIUC management
- Analyze emerging data from key clinical trials of immunotherapies in MIUC, including monotherapy, dual therapy, and combination therapy
- Discuss patient stratification in the treatment decision-making for MIUC, with emphasis on the potential impact of immunotherapies in each patient setting
|
|
1245-1400
|
|
SYMP-23: Luncheon Symposium: What Makes a Penile Implant Patient Happy? Best Practices for Improving Patient and Partner Satisfaction after PPI in 2021
Room: Sheikh Maktoum A
Chair: Steven Wilson, United States
|
|
At the end of this session, attendees will be able to:
- Review the common complications emerging from PPI surgery in the clinical practice and their impact on patient satisfaction.
- Analyze pre-, intra-, and postoperative strategies for improving outcomes and patient satisfaction following PPI.
- Discuss the current tools available for evaluating patient and partner satisfaction after PPI, including their limitations and opportunities for improvement.
|
|
1245-1415
|
|
Lunch Break
Room: Sheikh Rashid E
|
1415-1545
|
|
CO-01: Controversies in Urology 01 - High-Risk Prostate Cancer, Adjuvant & Salvage Therapies
Room: Sheikh Maktoum D
Co-Chairs: Laurence Klotz, Canada / Uğur Selek, Türkiye
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Explain the potential indications for post-operative radiotherapy after radical prostatectomy and discuss the role of adjuvant versus early salvage radiotherapy in the management of prostate cancer after radical prostatectomy
- Discuss management strategies incorporating androgen deprivation therapy and/or pelvic nodal irradiation after radical prostatectomy
- Determine the impact of genomic classifiers in the management of patients after radical prostatectomy
|
1415-1420
|
|
Introduction
Laurence Klotz, Canada Uğur Selek, Türkiye
|
1420-1440
|
|
Adjuvant Versus Early Salvage Radiotherapy After Prostatectomy
Derya Tilki, Germany
|
1440-1505
|
|
Androgen Deprivation Therapy, Treatment Field, and Time Related Toxicity With Adjuvant and Salvage Radiotherapy
Uğur Selek, Türkiye
|
1505-1525
|
|
Impact of Genomic Classifiers in the Management of Patients after Radical Prostatectomy
Todd Morgan, United States
|
1525-1540
|
|
Discussion
Laurence Klotz, Canada Todd Morgan, United States Uğur Selek, Türkiye
|
1540-1545
|
|
Concluding Remarks
Laurence Klotz, Canada Uğur Selek, Türkiye
|
|
1415-1525
|
|
CO-02: Controversies in Urology 02 - Sexual Dysfunction and Infertility: What Works and What Does Not?
Room: Ras Al Khaimah
Co-Chairs: Ates Kadıoğlu, Türkiye / Rajeev Kumar, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Discuss optimization efficacy and clinical results with the use of Xiaflex in patients with Peyronie’s Disease
- Understand the lessons learned and optimization of results in prosthetic surgery
- Explain the management and current challenges faced in ejaculatory dysfunction
- Recognize the challenges faced in male infertility during the COVID-19 era
|
1415-1420
|
|
Introduction
Ates Kadıoğlu, Türkiye Rajeev Kumar, India
|
1420-1435
|
|
Peyronie's Disease: Optimization of Efficacy and Clinical Results with the Use of Xiaflex
Carlo Bettocchi, Italy
|
1435-1440
|
|
Discussion
Carlo Bettocchi, Italy
|
1440-1455
|
|
Management of Complications of Prnilr Prosthesis
Ates Kadıoğlu, Türkiye
|
1455-1500
|
|
Discussion
Ates Kadıoğlu, Türkiye
|
1500-1515
|
|
Male Infertility: Challenges in COVID Era
Ates Kadıoğlu, Türkiye
|
1515-1520
|
|
Discussion
Ates Kadıoğlu, Türkiye
|
1520-1525
|
|
Closing Remarks
Ates Kadıoğlu, Türkiye Rajeev Kumar, India
|
|
1415-1545
|
|
MV-03: Master Videos 03 - Complex Upper-tract Reconstructive Surgery
Room: Sheikh Rashid A
Co-Chairs: Petr Macek, France / Kurt McCammon, United States
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Describe the use of buccal grafts for ureteral reconstruction
- Understand the use of the robot for IVC reconstruction after thrombectomy
- Describe Ureterocalycostomy indications and procedure
|
|
1415-1545
|
|
MP-04: Moderated ePoster Session 04 - BPO/LUTS/, Minimally Invasive Surgery/ Robotics
Room: Abu Dhabi B
Moderators: Mélanie Aubé-Peterkin, Canada / Yaser Saeedi, United Arab Emirates
|
1415-1545
|
|
ePoster Presentation
Presenters Abdulrahman Ahmad, Canada Abdulrahman Al Mulhim, Saudi Arabia Nordine Amara, France Deyan Anakievski, Bulgaria Anas Abdel Basit, United Kingdom Tejas Mistry, India Romy Mondschein, Australia Amit Patel, United Kingdom Mark Rochester, United Kingdom Claus Roehrborn, United States Truong Thanh Do, Vietnam
|
|
1415-1545
|
|
RF-01: Residents' Forum - Moderated ePoster Session
Room: Abu Dhabi A
Moderators: Tharwat Abdelghaffar, United Arab Emirates / Dean Elterman, Canada
|
|
1545-1615
|
|
Break
Room: Sheikh Rashid E
|
1615-1745
|
|
IC-16: Instructional Course 16 - Testosterone, the Prostate and Cardiovascular Disease: Addressing Safety and Efficacy in Testosterone Replacement Therapy
Room: Ras Al Khaimah
Chair: Brian Birch, United Kingdom
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Identify and distinguish between the different models of testosterone interaction with the prostate and the implications that these have for clinical practice
- Apply the basic science evidence that underpins the interaction between testosterone and the cardiovascular system to clinical settings
- Counsel patients appropriately regarding testosterone replacement therapy and efficacy of treatment, testosterone replacement therapy and cardiovascular disease risk, testosterone replacement therapy and prostate disease risk both benign and malignant
- Contribute to a safer and more appropriate prescribing practice for testosterone replacement therapy
|
1615-1620
|
|
Introduction
Brian Birch, United Kingdom
|
1620-1630
|
|
Relevant Basic Science (including Models of Interaction with the Prostate, the Cardiovascular System and Their Implications for Clinical Practice)
Brian Birch, United Kingdom
|
|
|
Testosterone Replacement Therapy:
|
1630-1640
|
|
Efficacy
Ryan Flannigan, Canada
|
1640-1650
|
|
Prostate Risk
Ryan Flannigan, Canada
|
1650-1700
|
|
Cardiovascular Risk
Rowland Rees, United Kingdom
|
1700-1710
|
|
Patient Selection and Management
Rowland Rees, United Kingdom
|
1710-1715
|
|
Q&A
|
1715-1740
|
|
Testosterone Replacement Therapy: Specific Scenarios - Panel Discussion
Brian Birch, United Kingdom Rowland Rees, United Kingdom
|
|
|
Prostate Cancer: Active Surveillance
|
|
|
Prostate Cancer: Post Treatment with Curative Intent (Surgery & Radiotherapy)
|
|
|
BPH
|
|
|
Pre-existing Cardiovascular Disease
|
1740-1745
|
|
Conclusions & Take-home Messages
Brian Birch, United Kingdom
|
|
1615-1745
|
|
IC-17: Instructional Course 17 - Risk Reducing Surgery in Urology: For Whom, When and How?
Room: Umm Al Quwain
Chair: Yiğit Akın, Türkiye
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Recall the description of prophylactic surgery in the urological field
- Determine a diagnostic assessment including laboratory and imaging methods application areas
- Outline techniques and advantages (quality of life and anxiety issues)
- Explain Surveillance and Future directions in Prophylactic Urological Surgery
- Describe the Current status of Prophylactic Urological Surgery
|
|
1615-1745
|
|
IS-02: Interactive Session 02 - Renal Transplantation Frontiers: Donation after Cardiac Death (DCD) Kidneys - All You Wanted to Know but Were Afraid to Ask!
Room: Sheikh Maktoum D
Co-Chairs: Jamal Rizvi, India / Puneet Sindhwani, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Review the basics of DCD, including end of life donor management, ethical considerations, and legal aspects, with focus on the current renal transplantation scenario in India
- Understand the policies and protocols of DCD procurement, from donor preparation to organ recovery
- Examine the clinical data supporting the role of renal biopsy pre- and post-implantation as well as the indications for machine perfusion in organ preservation
- Evaluate factors influencing organ transplant decision-making, including the criteria for DCD donor and DCD kidney assessments
|
1615-1620
|
|
Introduction
Puneet Sindhwani, United States
|
1620-1635
|
|
Back to the Basics: A Primer on DCD Kidneys - Introduction and Donor Management
Jamal Rizvi, India
|
1635-1650
|
|
DCD Procurement: Tricks of the Trade: How to Procure, Pitfalls and Recovery
Obi Ekwenna, United States
|
1650-1705
|
|
The Role of Renal Biopsy and Machine Perfusion: Indications and Interpretation of the Data
Patrick Luke, Canada
|
1705-1720
|
|
Clinical Decision Making: View from 30,000 feet - To Transplant or Not to Transplant a DCD Kidney
Puneet Sindhwani, United States
|
1720-1740
|
|
Case Presentations and Panel Discussion
Patrick Luke, Canada Jamal Rizvi, India Puneet Sindhwani, United States
|
1740-1745
|
|
Closing Remarks
Jamal Rizvi, India Puneet Sindhwani, United States
|
|
1615-1745
|
|
JS-05: Joint SIU-Society of Genitourinary Reconstructive Surgeons (GURS) Session
Room: Sheikh Rashid CDF
Co-Chairs: Jairam Eswara, United States / Reynaldo Gómez, Chile / Kurt McCammon, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Identify the complexities of the management of sex development and gender-affirming surgery and the current available tools for their treatment
- Recognize the pros and cons of reconstruction versus urinary diversion for the management of radiation induced urethral stenosis
- Analyze the current evidence to support endoscopic urethrotomy as a cost effective first line approach for anterior urethral strictures
- Judge the value of live surgery courses and their impact on surgical education, considering their cost and possible risks for the patients
|
1615-1642
|
|
Part 1: Topic-specific State-of-the-Art Lectures
|
1615-1630
|
|
State-of-the-Art Lecture: Surgery in Disorders of Sex Development: When and How?
Alaa El Ghoneimi, France
|
1630-1642
|
|
State-of-the-Art Lecture: Management of Regretful Patients after Gender-Affirming Surgery
Marta Bizic, Serbia
|
|
|
Part 2: Point-Counterpoint: Radiation-Induced Posterior Urethral Stenoses
|
1642-1650
|
|
Reconstruction Is My Choice!
Jessica DeLong, United States
|
1650-1658
|
|
Urinary Diversion Is My Choice!
Tamsin Greenwell, United Kingdom
|
1658-1703
|
|
Q&A
|
|
|
Part 3: Point-Counterpoint: Is Endoscopic Urethrotomy Cost-Effective as Primary Therapy in Anterior Urethral Stricture?
|
1703-1711
|
|
Yes, It Is!
Jairam Eswara, United States
|
1711-1719
|
|
No, Urethroplasty Is Better!
Kuncoro Adi, Indonesia
|
1719-1724
|
|
Q&A
|
|
|
Part 4: Point-Counterpoint: Are Live Surgery Courses Helpful and Worth the Cost?
|
1724-1742
|
|
Yes, They Are!
Pankaj Joshi, India
|
1732-1740
|
|
No, They Are Not!
Keith Rourke, Canada
|
1740-1745
|
|
Q&A
|
|
1615-1745
|
|
MV-04: Master Videos 04 - Laparoscopy Sans the Robot
Room: Sheikh Rashid A
Co-Chair: Chiruvella Mallikarjuna, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Learn the finer nuances in some common laparoscopic urological surgeries
- Identify some technical modifications in the techniques of lap pyeloplasty to improve surgical outcomes
- Recall that there are many different ways to excise a renal tumor and do the renography laparoscopically, few of those will be demonstrated
- Recognize that continence is of prime importance in RP and many maneuvers are there to improve it and are demonstrated
- Conclude that cystectomy done laparoscopically has to be done in a stepwise fashion and all the steps are learnt by this presentation
- Understand that early vascular control during lap adrenalectomy is needed to control blood pressure during surgery of functional adrenal tumors, which will be explained; live interaction will be possible during the presentation
|
1615-1617
|
|
Introduction
Chiruvella Mallikarjuna, India
|
1617-1632
|
|
Intraoperative Techniques to Improve Outcomes in Pyeloplasty
Eddie Chan, Hong Kong
|
1632-1647
|
|
Excision and Renorraphy Techniques in Lap Partial Nephrectomy
Renaud Bollens, Belgium
|
1647-1702
|
|
Laparoscopic Vesicovaginl Fistula
Chiruvella Mallikarjuna, India
|
1702-1717
|
|
Step-by-step Demonstration of Radical Cystectomy
Nicolae Crisan, Romania
|
1717-1732
|
|
Lap Adrenalectomy for Functional Adrenal Tumors
Rajeev Kumar, India
|
1732-1742
|
|
Discussion & Interaction with Audience
Eddie Chan, Hong Kong Nicolae Crisan, Romania Rajeev Kumar, India Chiruvella Mallikarjuna, India
|
1742-1745
|
|
Take-home Message
|
|
1615-1745
|
|
MP-05: Moderated ePoster Session 05 - Kidney, Ureter, Adrenals
Room: Abu Dhabi B
Moderators: Zaki Almallah, United Arab Emirates / Mohsen Elmekresh, United Arab Emirates
|
|
1615-1745
|
|
MP-06: Moderated ePoster Session 06 - Stones
Room: Abu Dhabi A
Moderator: Thomas Tailly, Belgium
|
1615-1745
|
|
ePoster Presentation
Vineet Gauhar, Singapore Romy Mondschein, Australia
Presenters Radhika Bhanot, United Kingdom Franck Bladou, France Angus Bruce, United Kingdom Shoubhik Chandra, India Waleed El-Shaer, Egypt Amr Elsawy, Egypt Petrisor Aurelian Geavlete, Romania Anne Hong, Australia Sofia Mesquita, Portugal Putu Angga Risky Raharja, Indonesia Aditya Prakash Sharma, India Mriganka Mani Sinha, United Kingdom Truong Thanh Do, Vietnam
|
|
Sunday, November 14
Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.
0730-0900
|
|
IC-18: Instructional Course 18 - Advanced Ureteroscopy
Room: Ras Al Khaimah
Chair: Michael Grasso, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Reinforce ureteroscopic technique and expand on new innovative treatments
- Comprehensive review of ureteroscopic lithotripsy
- Present current state of the art therapies for upper urinary tract urothelial carcinoma
- Present detailed management strategies for upper urinary tract obstruction
- Reinforce preventative measures and treatment strategies for complications associated with RIRS
|
|
0730-0900
|
|
IC-19: Instructional Course 19 - Técnicas Quirúrgicas para HPB: Paso a Paso (2nd Course in Spanish) [Surgical Techniques for BPH: Step by Step]
Room: Abu Dhabi B
Chair: Alejandro Rodriguez, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Demonstrate the step-by-step surgical technique from an expert panel
- Give tips and tricks to prevent complications
- Learn how to identify best surgical options for different clinical scenarios
|
0730-0735
|
|
Introducción
Alejandro Rodriguez, United States
|
0735-0750
|
|
Vapor de agua transuretral para HPB bajo anestesia local: paso a paso
Alejandro Rodriguez, United States
|
0750-0805
|
|
HoLEP: paso a paso
Mariano Sebastian González, Argentina
|
0805-0820
|
|
Resección / enucleación con láser de tulio: paso a paso
Tomás Olmedo, Chile
|
0820-0835
|
|
Enucleación endoscópica bipolar: paso a paso
José Gadú Campos Salcedo, Mexico
|
0835-0855
|
|
Preguntas y respuestas
José Gadú Campos Salcedo, Mexico Mariano Sebastian González, Argentina Tomás Olmedo, Chile Alejandro Rodriguez, United States
|
0855-0900
|
|
Comentarios finales
Alejandro Rodriguez, United States
|
|
0800-0900
|
|
MC-05: Master Class 05 - Biomarkers in Cancer
Room: Sheikh Rashid A
Co-Chairs: Sia Daneshmand, United States / Seth Lerner, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Differentiate between molecular subtypes of bladder cancer
- Explain the role of immune-related biomarkers of bladder cancer
- Understand what serum biomarkers are in invasive bladder cancer
- Learn about DDR mutations and their response to chemotherapy
- Apply case-based knowledge to clinical applications
|
0800-0805
|
|
Introduction
Sia Daneshmand, United States Seth Lerner, United States
|
0805-0815
|
|
Molecular Subtypes of Bladder Cancer
Seth Lerner, United States
|
0815-0825
|
|
Immune-related Biomarkers of Bladder Cancer
Murat Bozlu, Turkey
|
0825-0835
|
|
Serum Biomarkers in Invasive Bladder Cancer
Sia Daneshmand, United States
|
0835-0845
|
|
DDR Mutations and Response to Chemotherapy
Wassim Kassouf, Canada
|
0845-0900
|
|
Clinical Applications
Moderator: Badrinath Konety, United States Panelists Murat Bozlu, Turkey Sia Daneshmand, United States Seth Lerner, United States
|
|
0800-0900
|
|
MC-06: Master Class 06 - Undescended Testis (UDT)
Room: Abu Dhabi A
Chair: Marta Bizic, Serbia
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Define modalities of treatment for UDT in adults, and indications for orchidectomy or testis preservation
- Acknowledge protocols for non-palpable testis in children and options for management of intraabdominal testis
- Identify advantages and disadvantages of different surgical approaches for UDT
- Be able to recognize acquired UDT and conduct proper treatment
|
|
0800-0900
|
|
MC-07: Master Class 07 - Complex Reconstruction (Lower-tract)
Room: Dubai CD
Co-Chairs: Mélanie Aubé-Peterkin, Canada / Jaspreet S. Sandhu, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Describe tissue engineering options for complex lower tract reconstruction
- Analyze and discuss options for surgical care and reconstruction of complex lower urinary tract disease
- Recognize the importance of patient experience when addressing complex lower tract reconstruction
|
0800-0803
|
|
Introduction
Mélanie Aubé-Peterkin, Canada
|
0803-0815
|
|
Tissue Engineering for Urethral Reconstruction
Jack M. Zuckerman, United States
|
0815-0827
|
|
Robotic Complex Vesicovaginal Fistula Repair
Shrawan Kumar Singh, India
|
0827-0839
|
|
What the General Urologist Needs to Know about Gender Reassignment Surgery
Marta Bizic, Serbia
|
0839-0851
|
|
Urinary Diversion: Indications and Patient Experience
Ouida Lenaine Westney, United States
|
0851-0857
|
|
Q&A
Mélanie Aubé-Peterkin, Canada Marta Bizic, Serbia Jaspreet S. Sandhu, United States Ouida Lenaine Westney, United States Jack M. Zuckerman, United States
|
0857-0900
|
|
Take-home Message
Jaspreet S. Sandhu, United States
|
|
0900-1100
|
|
PL-03: Plenary 03
Room: Sheikh Rashid CDF
Honorary Chairs: Jean de la Rosette, Türkiye / Reynaldo Gómez, Chile
|
0900-0905
|
|
Welcome
Reynaldo Gómez, Chile
|
0905-0935
|
|
2020 and 2021 Albert-Schweitzer Award Lectures
|
|
|
2020 Award Winner - Lecture Title: Crossing Sub-Saharan Africa Teaching Management of Neglected Tropical Urological Diseases
Serigne Magueye Gueye, Senegal
|
|
|
2021 Award Winner - Lecture Title: Urology Subspecialty - Developing Nations Perspective
Narmada P. Gupta, India
|
0935-0950
|
|
European Association of Urology (EAU) Lecture: Co-morbidity Tailored Treatment of Prostate Cancer
Arnulf Stenzl, Germany
Learning Objectives: At the end of Dr. Stenzl's lecture, attendees will be able to:
- Differentiate between various forms of treatment, i.e. conservative, interventional, surgical in prostate cancer patients with comorbidities
- Differentiate between regionally advanced, oligometastatic and metastatic (de novo and recurrent) disease and the impact of patients' comorbidities
- Show possible pathomechanisms of diabetes mellitus which could interfere with the prognosis of prostate cancer
|
0950-1005
|
|
American Urological Association (AUA) Lecture: Renal Mass Guideline Update
Sam Chang, United States
Learning Objectives: At the end of Dr. Chang's lecture, attendees will be able to:
- Recognize the importance of risk-stratified diagnosis, care, and surveillance follow-up
- Provide multi-disciplinary options for renal cancer
- Update the criteria and role of active surveillance
- Promote the need for continued clinical trials
|
1005-1020
|
|
State-of-the-Art Lecture: Testicular Cancer (New Markers, Changing Face of Testicular Cancer)
Sia Daneshmand, United States
|
1020-1030
|
|
State-of-the-Art Lecture: Priapism - Pathophysiology and Clinical Diagnostic Approach
Asif Muneer, United Kingdom
|
|
|
Urological Infections and Inflammations
|
1030-1040
|
|
What's New in Urological Infections
Kurt Naber, Germany
|
1040-1050
|
|
GUTB and Atypical Bacterial UTI
Ekaterina Kulchavenya, Russia
|
1050-1100
|
|
An Update on the Management of IC in 2021
Rajesh Taneja, India
|
|
1100-1115
|
|
Break
Room: Sheikh Rashid E
|
1115-1245
|
|
JS-06: Joint SIU-Society of Urologic Oncology (SUO)/EAU Section of Oncological Urology (ESOU)
Room: Abu Dhabi B
Co-Chairs: Seth Lerner, United States / Maria Carmen Mir, Spain
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Recognize the impact of current international guidelines on the management of patients with invasive bladder cancer
- Recall the clinical, pathologic and molecular characteristics that impact on selection of patients for neoadjuvant chemotherapy
- Discuss the latest advances in robotic and minimally invasive surgical techniques in the management of invasive bladder cancer
- Evaluate recent clinical trial results and new combination therapies for the treatment of urothelial bladder cancer including BCG unresponsive and upper tract tumors
|
1115-1120
|
|
Introduction
Seth Lerner, United States Maria Carmen Mir, Spain
|
1120-1205
|
|
Part One: 3 State-of-the-Art Lectures
|
1120-1135
|
|
Overview of AUA/SUO/EAU Guidelines for Muscle Invasive Disease
Michael Cookson, United States
|
1135-1150
|
|
Selecting Patients for Neoadjuvant Chemotherapy Using Molecular Subtyping: Are We There Yet?
Sima Porten, United States
|
1151-1205
|
|
Contemporary Treatment of Upper Tract Urothelial Carcinoma
Peter Black, Canada
|
1205-1225
|
|
Part Two: Video Debate: Open Radical Cystectomy and Urinary Diversion vs Robotic Radical Cystectomy and Intracorporeal Urinary Diversion; What Does the Data Show?
|
1205-1215
|
|
Robotic
Sanjay G. Patel, United States
|
1215-1225
|
|
Carcinoma in Situ of the Bladder: Where Are We Now?
Juan Palou, Spain
|
1225-1245
|
|
Part Three: Panel Discussion: Difficult Cases in the Management of Urothelial Carcinoma of the Bladder
Panelists Peter Black, Canada Seth Lerner, United States Maria Carmen Mir, Spain Morgan Roupret, France
|
|
1115-1245
|
|
MP-07: Moderated ePoster Session 07 - Prostate Cancer
Room: Ras Al Khaimah
Moderators: Vipan Bhatia, United Arab Emirates / Andrés Hernández-Porras, Mexico
|
1115-1245
|
|
ePoster Presentation
Presenters Ali Abdullah, Canada Shusuke Akamatsu, Japan Meyada Ali, United Kingdom Mevlana Derya Balbay, Türkiye Ezequiel Becher, Argentina Muhammad Bulbul, Lebanon Anthony Chi-Fai Ng, Hong Kong Marlon Perera, Australia Gabor Rosta, Austria Fayek Taha, France Samuel Tremblay, Canada Christian Wetterauer, Switzerland
|
|
1115-1245
|
|
MP-08: Moderated ePoster Session 08 - Reconstruction
Room: Abu Dhabi A
Moderators: Mudhar Nazar Hasan, United Arab Emirates / Keshavamurthy Ramaiah, India
|
1115-1245
|
|
ePoster Presentation
Presenters Mohammed Abdel-Rassoul, Egypt John T. Barnard, United States Marta Bizic, Serbia Joel Gelman, United States Sakineh Hajebrahimi, Iran Deepak Krishnappa, India Michael Metro, United States Nadav Milk, Israel Poongkodi Nagappan, Malaysia Ole Jacob Nilsen, Norway Walid Shahrour, Canada Taras Shatylko, Russia Corey Weinstein, United States Xu Zhang, People's Republic of China
|
|
1245-1415
|
|
Lunch Break
Room: Sheikh Rashid E
|
1415-1545
|
|
MV-05: Master Videos 05 - Robotics: State of the Art
Room: Abu Dhabi B
Co-Chairs: Mihir Desai, United States / Aditya Prakash Sharma, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the technical steps of cutting edge robotic urologic procedures such as SP prostatectomy, SP partial nephrectomy, Intracorporeal neobladder, and IVC thrombectomy
- Learn how to prevent and manage complications
- Review tips, tricks and troubleshooting the various procedures and the robotic systems involved
|
|
1415-1545
|
|
MV-06: Master Videos 06 - RIRS and PCNL
Room: Sheikh Rashid A
Co-Chairs: Daniel Pérez-Fentes, Spain / Thomas Tailly, Belgium
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Identify the critical steps in RIRS, PCNL and ECIRS.
- Evaluate the pros and cons of the different endourological approaches for stone treatment
- Manage the different treatment options in a comprehensive manner
|
1415-1420
|
|
Introduction
Daniel Pérez-Fentes, Spain Thomas Tailly, Belgium
|
1420-1435
|
|
RIRS in a Conventional Case, Step by Step
Thomas Hsueh, Taiwan
|
1435-1440
|
|
Discussion
Thomas Hsueh, Taiwan
|
1440-1455
|
|
RIRS in Challenging Situations: How to Make the Most of New Technologies
Thomas Tailly, Belgium
|
1455-1500
|
|
Discussion
Thomas Tailly, Belgium
|
1500-1515
|
|
Miniaturized PCNL and Standard PERC: Basic Steps and Clinical Application
Vitor Cavadas, Portugal
|
1515-1520
|
|
Discussion
|
1520-1535
|
|
ECIRS and Mini-ECIRS: Why and How
Daniel Pérez-Fentes, Spain
|
1535-1540
|
|
Discussion
Daniel Pérez-Fentes, Spain
|
1540-1545
|
|
Take-home Message
Daniel Pérez-Fentes, Spain Thomas Tailly, Belgium
|
|
1415-1545
|
|
MP-09: Moderated ePoster Session 09 - Andrology, Infertility, Penis/Testis/Urethra, Trauma
Room: Abu Dhabi A
Moderator: Rajeev Sood, India
|
1415-1545
|
|
ePoster Presentation
Presenters Liaqat Ali, Pakistan Mohammad H. Alkandari, Kuwait Amandeep Arora, India Nadia Ali Benali, France Franck Bladou, France Waleed El-Shaer, Egypt Ahmad Haider, Germany Karim Sultan Haider, Germany Yudhistira Pradnyan Kloping, Indonesia Brian Miles, United States Dimas Tri Prasetyo, Indonesia Taras Shatylko, Russia
|
|
1415-1545
|
|
MVP-02: Moderated Video Session 02 - Kidney and Ureter - Benign Diseases, Minimally Invasive Surgery/Robotics, Stones
Room: Ras Al Khaimah
Moderators: Salam Alhasani, United Arab Emirates / Sia Daneshmand, United States
|
|
Hamdy Abotaleb• Moderated Video Session 01 - BTO/LUTS, Miscellaneous, Pediatric Urology, Reconstruction
Moderator • Biography
Sebastien Beley• Luncheon Symposium: What Makes a Penile Implant Patient Happy? Best Practices for Improving Patient and Partner Satisfaction after PPI in 2021
Faculty • Biography
Rafael Carrion• Luncheon Symposium: What Makes a Penile Implant Patient Happy? Best Practices for Improving Patient and Partner Satisfaction after PPI in 2021
Faculty • Biography
James Catto• Luncheon Symposium: Immunotherapy in MIUC: Current Practices and Future Perspectives
Chair • Biography
Mohsen Elmekresh• Moderated ePoster Session 03 - Infections & Inflammatory Disease
Moderator• Emirates Urological Society (EUS) Programme
Expert Comments• Moderated ePoster Session 05 - Kidney, Ureter, Adrenals
Moderator • Biography
Dean Elterman• SIU Tips and Tricks Session - SIU Academy & SIU Journal
Consensus Pros• Instructional Course 04 - Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Chair Closing Remarks• Moderated ePoster Session 02 - Pediatrics/ Miscellaneous/ Basic Science
ePoster Presentation• Instructional Course 04 - Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Introduction to Novel BPH Therapies• Emirates Urological Society (EUS) Programme
MIST of BPH• SIU Innovators' Symposium
Part 2: Telementoring• Instructional Course 04 - Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Q&A Q&A Stents UroLift• Residents' Forum - Moderated ePoster Session
Moderator• 6th SIU Global Nurses' Educational Symposium
Interpretation and Artifacts Neuromodulation Q&A • Biography
Wissam Kamal• 9th Symposium on Affordable New Technologies in Urology (SANTU) and Best Affordable New Technologies in Urology Contest (BANTUC)
Moderated Posters• Demo Session: Tips and Tricks in fURS
Chair Chair • Biography
David Ralph• Luncheon Symposium: What Makes a Penile Implant Patient Happy? Best Practices for Improving Patient and Partner Satisfaction after PPI in 2021
Faculty • Biography
Enrique Rijo• Instructional Course 04 - Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Aquablation• Moderated Video Session 01 - BTO/LUTS, Miscellaneous, Pediatric Urology, Reconstruction
ePoster Presentation• Instructional Course 04 - Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Q&A • Biography
Rajeev Sood• Moderated ePoster Session 09 - Andrology, Infertility, Penis/Testis/Urethra, Trauma
Moderator • Biography